| Year |
Citation |
Score |
| 2025 |
Salazar de Pablo G, Perez-Rodriguez V, de Otazu Olivares J, Camacho-Rubio J, Sharma A, Catalán A, Breedvelt J, Aymerich C, Pop M, Moreno C, Kelleher I, Anderson J, Fusar-Poli P, Correll CU, Young AH. Development and Predictors of Bipolar Disorder in Children and Adolescents with Depressive Disorders A Systematic Review, Meta-analysis and Meta-regression. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-37. PMID 39773691 DOI: 10.1192/j.eurpsy.2024.1814 |
0.305 |
|
| 2024 |
Bell CJM, Mehta M, Mirza L, Young AH, Beck K. Glutathione alterations in depression: a meta-analysis and systematic review of proton magnetic resonance spectroscopy studies. Psychopharmacology. PMID 39708105 DOI: 10.1007/s00213-024-06735-1 |
0.328 |
|
| 2024 |
Anmella G, Corponi F, Li BM, Mas A, Garriga M, Sanabra M, Pacchiarotti I, Valentí M, Grande I, Benabarre A, Giménez-Palomo A, Agasi I, Bastidas A, Cavero M, Bioque M, ... ... Young AH, et al. Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study. Bjpsych Open. 10: e137. PMID 39086306 DOI: 10.1192/bjo.2024.716 |
0.323 |
|
| 2024 |
Fu CHY, Antoniades M, Erus G, Garcia JA, Fan Y, Arnone D, Arnott SR, Chen T, Choi KS, Fatt CC, Frey BN, Frokjaer VG, Ganz M, Godlewska BR, Hassel S, ... ... Young AH, et al. Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo. Nature. Mental Health. 2: 164-176. PMID 38948238 DOI: 10.1038/s44220-023-00187-w |
0.308 |
|
| 2024 |
Gottlieb N, Young AH. Antidepressants and Bipolar Disorder: The Plot Thickens. The American Journal of Psychiatry. 181: 575-577. PMID 38946275 DOI: 10.1176/appi.ajp.20240411 |
0.317 |
|
| 2023 |
Fagiolini A, González Pinto A, Miskowiak KW, Morgado P, Young AH, Vieta E. Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights. Neuropsychiatric Disease and Treatment. 19: 2817-2831. PMID 38155994 DOI: 10.2147/NDT.S434130 |
0.32 |
|
| 2023 |
Anmella G, Mas A, Sanabra M, Valenzuela-Pascual C, Valentí M, Pacchiarotti I, Benabarre A, Grande I, De Prisco M, Oliva V, Fico G, Giménez-Palomo A, Bastidas A, Agasi I, Young AH, et al. Electrodermal activity in bipolar disorder: Differences between mood episodes and clinical remission using a wearable device in a real-world clinical setting. Journal of Affective Disorders. PMID 37865347 DOI: 10.1016/j.jad.2023.10.125 |
0.321 |
|
| 2023 |
Fagiolini A, González-Pinto A, Miskowiak KW, Morgado P, Young AH, Vieta E. Role of trazodone in treatment of major depressive disorder: an update. Annals of General Psychiatry. 22: 32. PMID 37660092 DOI: 10.1186/s12991-023-00465-y |
0.354 |
|
| 2023 |
Anmella G, Corponi F, Li BM, Mas A, Sanabra M, Pacchiarotti I, Valentí M, Grande I, Benabarre A, Giménez-Palomo A, Garriga M, Agasi I, Bastidas A, Cavero M, Fernández-Plaza T, ... ... Young AH, et al. Exploring digital biomarkers of illness activity in mood episodes: hypotheses generating and model development study. Jmir Mhealth and Uhealth. PMID 36939345 DOI: 10.2196/45405 |
0.341 |
|
| 2023 |
Husain MI, Chaudhry IB, Khoso AB, Kiran T, Khan N, Ahmad F, Hodsoll J, Husain MO, Naqvi HA, Nizami AT, Chaudhry N, Khan HA, Minhas F, Meyer JH, Ansari MA, ... ... Young AH, et al. Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial. Jama Network Open. 6: e230147. PMID 36808239 DOI: 10.1001/jamanetworkopen.2023.0147 |
0.316 |
|
| 2023 |
Fu CHY, Erus G, Fan Y, Antoniades M, Arnone D, Arnott SR, Chen T, Choi KS, Fatt CC, Frey BN, Frokjaer VG, Ganz M, Garcia J, Godlewska BR, Hassel S, ... ... Young AH, et al. AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale. Bmc Psychiatry. 23: 59. PMID 36690972 DOI: 10.1186/s12888-022-04509-7 |
0.343 |
|
| 2023 |
Strawbridge R, Yalin N, Orfanos S, Young AH. Acetazolamide for Bipolar Disorders: A Scoping Review. Brain Sciences. 13. PMID 36672121 DOI: 10.3390/brainsci13010140 |
0.312 |
|
| 2022 |
Alexander L, Young AH. Recent Advances in the Psychopharmacology of Major Depressive Disorder. Bjpsych Advances. 29: 117-130. PMID 39649121 DOI: 10.1192/bja.2022.14 |
0.328 |
|
| 2022 |
Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression. Lancet (London, England). PMID 36535295 DOI: 10.1016/S0140-6736(22)02080-3 |
0.304 |
|
| 2022 |
McIntyre RS, Alda M, Baldessarini RJ, Bauer M, Berk M, Correll CU, Fagiolini A, Fountoulakis K, Frye MA, Grunze H, Kessing LV, Miklowitz DJ, Parker G, Post RM, Swann AC, ... ... Young A, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 21: 364-387. PMID 36073706 DOI: 10.1002/wps.20997 |
0.309 |
|
| 2022 |
Strawbridge R, Alexander L, Richardson T, Young AH, Cleare AJ. Is there a 'bipolar iceberg' in UK primary care psychological therapy services? Psychological Medicine. 1-10. PMID 35920607 DOI: 10.1017/S0033291722002343 |
0.301 |
|
| 2022 |
Van Assche E, Ramos-Quiroga JA, Pariante CM, Sforzini L, Young AH, Flossbach Y, Gold SM, Hoogendijk WJG, Baune BT, Maron E. Erratum to "Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100-116]". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 63: 4-5. PMID 35896050 DOI: 10.1016/j.euroneuro.2022.06.011 |
0.319 |
|
| 2022 |
Van Assche E, Antoni Ramos-Quiroga J, Pariante CM, Sforzini L, Young AH, Flossbach Y, Gold SM, Hoogendijk WJG, Baune BT, Maron E. Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 60: 100-116. PMID 35671641 DOI: 10.1016/j.euroneuro.2022.05.007 |
0.303 |
|
| 2021 |
Perez CSH, Ciufolini S, Sood PG, Krivoy A, Young AH, Murray RM, Ismail K, Atakan Z, Greenwood K, Smith S, Gaughran F, Juruena MF. Predictive value of cardiometabolic biomarkers and depressive symptoms for symptom severity and quality of life in patients with psychotic disorders. Journal of Affective Disorders. PMID 34699852 DOI: 10.1016/j.jad.2021.10.038 |
0.315 |
|
| 2021 |
Azim L, Hindmarch P, Browne G, Chadwick T, Clare E, Courtney P, Dixon L, Duffelen N, Fouweather T, Geddes JR, Goudie N, Harvey S, Helter T, Holstein EM, Martin G, ... ... Young AH, et al. Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study). Bmc Psychiatry. 21: 334. PMID 34225686 DOI: 10.1186/s12888-021-03322-y |
0.333 |
|
| 2021 |
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, ... ... Young AH, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251 |
0.348 |
|
| 2020 |
Malhi GS, Bell E, Singh A, Bassett D, Berk M, Boyce P, Bryant R, Gitlin M, Hamilton A, Hazell P, Hopwood M, Lyndon B, McIntyre RS, Morris G, Mulder R, ... ... Young A, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood Disorders: Major Depression Summary. Bipolar Disorders. PMID 33320412 DOI: 10.1111/bdi.13035 |
0.304 |
|
| 2020 |
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, ... ... Young AH, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-20. PMID 33289425 DOI: 10.1080/15622975.2020.1851052 |
0.338 |
|
| 2020 |
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet (London, England). 396: 1841-1856. PMID 33278937 DOI: 10.1016/S0140-6736(20)31544-0 |
0.367 |
|
| 2020 |
Zazula R, Husain MI, Mohebbi M, Walker AJ, Chaudhry IB, Khoso AB, Ashton MM, Agustini B, Husain N, Deakin J, Young AH, Berk M, Kanchanatawan B, Ng CH, Maes M, et al. Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials. The Australian and New Zealand Journal of Psychiatry. 4867420965697. PMID 33092404 DOI: 10.1177/0004867420965697 |
0.349 |
|
| 2020 |
Furio MA, Popovic D, Vieta E, Stukalin Y, Hagin M, Torrent C, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study. Bipolar Disorders. PMID 32959482 DOI: 10.1111/bdi.12994 |
0.446 |
|
| 2020 |
Husain MI, Deakin B, Chaudhry IB, Mulsant BH, Young AH. Trial failures of anti-inflammatory drugs in depression - Authors' reply. The Lancet. Psychiatry. 7: 837-838. PMID 32949511 DOI: 10.1016/S2215-0366(20)30391-6 |
0.304 |
|
| 2020 |
Frigerio S, Strawbridge R, Young AH. The impact of caffeine consumption on clinical symptoms in patients with bipolar disorder: A systematic review. Bipolar Disorders. PMID 32949106 DOI: 10.1111/bdi.12990 |
0.4 |
|
| 2020 |
Wilks Z, Perkins AM, Cooper A, Pliszka B, Cleare AJ, Young AH. Relationship of a big five personality questionnaire to the symptoms of affective disorders. Journal of Affective Disorders. 277: 14-20. PMID 32777603 DOI: 10.1016/J.Jad.2020.07.122 |
0.396 |
|
| 2020 |
Memon A, Rogers I, Fitzsimmons SMDD, Carter B, Strawbridge R, Hidalgo-Mazzei D, Young AH. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies. The British Journal of Psychiatry : the Journal of Mental Science. 1-12. PMID 32716281 DOI: 10.1192/bjp.2020.128 |
0.31 |
|
| 2020 |
Corponi F, Anmella G, Pacchiarotti I, Samalin L, Verdolini N, Popovic D, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G, Vieta E, Murru A. Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study. Translational Psychiatry. 10: 241. PMID 32684621 DOI: 10.1038/s41398-020-00922-2 |
0.379 |
|
| 2020 |
Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ. Historic psychedelic drug trials and the treatment of anxiety disorders. Depression and Anxiety. PMID 32627308 DOI: 10.1002/da.23065 |
0.377 |
|
| 2020 |
Yalin N, Young AH. Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options? Neuropsychiatric Disease and Treatment. 16: 1459-1472. PMID 32606699 DOI: 10.2147/NDT.S245166 |
0.444 |
|
| 2020 |
Strawbridge R, Tsapekos D, Hodsoll J, Mantingh T, Yalin N, McCrone P, Boadu J, Macritchie K, Cella M, Reeder C, Fish J, Wykes T, Young AH. Cognitive Remediation Therapy for patients with bipolar disorder: A randomised proof-of-concept trial. Bipolar Disorders. PMID 32583630 DOI: 10.1111/bdi.12968 |
0.37 |
|
| 2020 |
Colasanti A, Bugiardini E, Amawi S, Poole OV, Skorupinska I, Skorupinska M, Germain L, Kozyra D, Holmes S, James N, Woodward CE, Quinlivan R, Young AH, Hanna MG, Pitceathly RDS. Primary mitochondrial diseases increase susceptibility to bipolar affective disorder. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32527838 DOI: 10.1136/jnnp-2020-323632 |
0.398 |
|
| 2020 |
Jones BDM, Daskalakis ZJ, Carvalho AF, Strawbridge R, Young AH, Mulsant BH, Husain MI. Inflammation as a treatment target in mood disorders: review. Bjpsych Open. 6: e60. PMID 32498754 DOI: 10.1192/bjo.2020.43 |
0.333 |
|
| 2020 |
Carter B, Strawbridge R, Husain MI, Jones BDM, Short R, Cleare AJ, Tsapekos D, Patrick F, Marwood L, Taylor RW, Mantingh T, de Angel V, Nikolova VL, Carvalho AF, Young AH. Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis. International Review of Psychiatry (Abingdon, England). 1-14. PMID 32498577 DOI: 10.1080/09540261.2020.1765748 |
0.342 |
|
| 2020 |
Jauhar S, Arnone D, Young AH. Changing the clinical landscape for treatment of bipolar disorder- to be (cautiously) welcomed. Bipolar Disorders. PMID 32478447 DOI: 10.1111/bdi.12945 |
0.398 |
|
| 2020 |
Harrison P, Carr E, Goldsmith K, Young AH, Ashworth M, Fennema D, Barrett B, Zahn R. Study protocol for the antidepressant advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care: a feasibility study. Bmj Open. 10: e035905. PMID 32448796 DOI: 10.1136/Bmjopen-2019-035905 |
0.309 |
|
| 2020 |
Hieronymus F, Jauhar S, Østergaard SD, Young AH. One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials. Journal of Psychopharmacology (Oxford, England). 269881120922950. PMID 32448035 DOI: 10.1177/0269881120922950 |
0.394 |
|
| 2020 |
Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, Naqvi HA, Minhas FA, Carvalho AF, Meyer JH, Deakin B, Mulsant BH, Husain N, Young AH. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial. The Lancet. Psychiatry. 7: 515-527. PMID 32445690 DOI: 10.1016/S2215-0366(20)30138-3 |
0.416 |
|
| 2020 |
Husain MI, Deakin B, Chaudhry IB, Mulsant BH, Young AH. Assessing adjunctive treatments for bipolar depression. The Lancet. Psychiatry. 7: 478-479. PMID 32445679 DOI: 10.1016/S2215-0366(20)30193-0 |
0.409 |
|
| 2020 |
Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J. Psychedelic treatment of functional neurological disorder: a systematic review. Therapeutic Advances in Psychopharmacology. 10: 2045125320912125. PMID 32435447 DOI: 10.1177/2045125320912125 |
0.395 |
|
| 2020 |
Berger T, Lee H, Young AH, Aarsland D, Thuret S. Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease. Trends in Molecular Medicine. PMID 32418723 DOI: 10.1016/j.molmed.2020.03.010 |
0.373 |
|
| 2020 |
Corponi F, Anmella G, Verdolini N, Pacchiarotti I, Samalin L, Popovic D, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G, Vieta E, Murru A. Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32409261 DOI: 10.1016/j.euroneuro.2020.03.017 |
0.384 |
|
| 2020 |
Taylor RW, Marwood L, Oprea E, DeAngel V, Mather S, Valentini B, Zahn R, Young AH, Cleare AJ. Pharmacological augmentation in unipolar depression: a guide to the guidelines. The International Journal of Neuropsychopharmacology. PMID 32402075 DOI: 10.1093/Ijnp/Pyaa033 |
0.373 |
|
| 2020 |
Wajs E, Aluisio L, Holder R, Daly EJ, Lane R, Lim P, George JE, Morrison RL, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, et al. Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2). The Journal of Clinical Psychiatry. 81. PMID 32316080 DOI: 10.4088/JCP.19m12891 |
0.338 |
|
| 2020 |
Stokes PRA, Jokinen T, Amawi S, Qureshi M, Husain MI, Yatham LN, Strang J, Young AH. Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720915420. PMID 32302221 DOI: 10.1177/0706743720915420 |
0.439 |
|
| 2020 |
Husain MI, Cullen C, Umer M, Carvalho AF, Kloiber S, Meyer JH, Ortiz A, Knyahnytska Y, Husain MO, Giddens J, Diniz BS, Wang W, Young AH, Mulsant BH, Daskalakis ZJ. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2). Bmc Psychiatry. 20: 173. PMID 32295565 DOI: 10.1186/S12888-020-02553-9 |
0.396 |
|
| 2020 |
Juruena MF, Young AH, Hodsoll J, Lewis G, Veale D. Efficacy and Safety of Bright Light Therapy for Bipolar Depression. Psychiatry and Clinical Neurosciences. PMID 32248612 DOI: 10.1111/pcn.13005 |
0.341 |
|
| 2020 |
Herane-Vives A, Papadopoulos A, de Angel V, Chua KC, Soto L, Chalder T, Young AH, Cleare AJ. Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens. Journal of Affective Disorders. 267: 307-314. PMID 32217231 DOI: 10.1016/j.jad.2020.01.146 |
0.343 |
|
| 2020 |
McAllister-Williams RH, Arango C, Blier P, Demyttenaere K, Falkai P, Gorwood P, Hopwood M, Javed A, Kasper S, Malhi GS, Soares JC, Vieta E, Young AH, Papadopoulos A, Rush AJ. The identification, assessment and management of difficult-to-treat depression: An international consensus statement. Journal of Affective Disorders. 267: 264-282. PMID 32217227 DOI: 10.1016/J.Jad.2020.02.023 |
0.363 |
|
| 2020 |
Herane-Vives A, Arnone D, de Angel V, Papadopoulos A, Wise T, Alameda L, Chua KC, Young AH, Cleare AJ. Cortisol levels in unmedicated patients with unipolar and bipolar major depression using hair and saliva specimens. International Journal of Bipolar Disorders. 8: 15. PMID 32133545 DOI: 10.1186/s40345-020-0180-x |
0.46 |
|
| 2020 |
Wise T, Patrick F, Meyer N, Mazibuko N, Oates AE, van der Bijl AHM, Danjou P, O'Connor SM, Doolin E, Wooldridge C, Rathjen D, Macare C, Williams SCR, Perkins A, Young AH. Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder. Biological Psychiatry. PMID 32107005 DOI: 10.1016/J.Biopsych.2019.12.013 |
0.366 |
|
| 2020 |
Perkins AM, Bley JG, Cleare AJ, Young AH, Corr PJ, Dohrenbusch R, Ettinger U. Threat-sensitivity in affective disorders: A case-control study. Journal of Affective Disorders. 266: 595-602. PMID 32056932 DOI: 10.1016/J.Jad.2020.01.074 |
0.447 |
|
| 2020 |
Juruena MF, Eror F, Cleare AJ, Young AH. The Role of Early Life Stress in HPA Axis and Anxiety. Advances in Experimental Medicine and Biology. 1191: 141-153. PMID 32002927 DOI: 10.1007/978-981-32-9705-0_9 |
0.41 |
|
| 2020 |
Tsapekos D, Strawbridge R, Cella M, Wykes T, Young AH. Do we really need a "new" cognitive therapy for bipolar disorder? Paradigm refinements and treatment mechanisms for cognitive remediation. Bipolar Disorders. PMID 31965658 DOI: 10.1111/Bdi.12890 |
0.33 |
|
| 2020 |
Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J. 21 Psychedelic treatment of functional neurological disorder – a systematic review Journal of Neurology, Neurosurgery, and Psychiatry. 91. DOI: 10.1136/Jnnp-2020-Bnpa.38 |
0.387 |
|
| 2020 |
Husain MI, Chaudhry I, Husain N, Khoso A, Husain MO, Hamirani M, Minhas F, Carvalho A, Hodsoll J, Meyer J, Deakin B, Mulsant B, Young A. Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression: A Multicenter, Factorial Design Randomized Controlled Trial Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1059 |
0.372 |
|
| 2020 |
Jelen LA, Young AH. The Treatment of Bipolar Depression: Current Status and Future Perspectives Current Behavioral Neuroscience Reports. 7: 1-14. DOI: 10.1007/S40473-020-00200-X |
0.42 |
|
| 2019 |
Oyesanya M, Harmer CJ, Young AH. Editorial: Cognition in Mood Disorders. Frontiers in Psychiatry. 10: 1013. PMID 32082197 DOI: 10.3389/fpsyt.2019.01013 |
0.364 |
|
| 2019 |
Stokes PRA, Yalin N, Mantingh T, Colasanti A, Patel R, Bellivier F, Leboyer M, Henry C, Kahn JP, Etain B, Young AH. Unipolar mania: Identification and characterisation of cases in France and the United Kingdom. Journal of Affective Disorders. 263: 228-235. PMID 31818781 DOI: 10.1016/j.jad.2019.11.024 |
0.431 |
|
| 2019 |
Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, Bousman C, Smith DJ, Bioque M, Clements CC, Loo C, Vila-Rodriguez F, Minelli A, Mickey BJ, Milev R, ... ... Young AH, et al. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic). European Archives of Psychiatry and Clinical Neuroscience. PMID 31802253 DOI: 10.1007/S00406-019-01087-W |
0.418 |
|
| 2019 |
Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Tohen M, Kasper S, Moeller HJ. The CINP guidelines on the definition and the evidence-based interventions for treatment-resistant Bipolar disorder. The International Journal of Neuropsychopharmacology. PMID 31802122 DOI: 10.1093/Ijnp/Pyz064 |
0.355 |
|
| 2019 |
Davies MR, Kalsi G, Armour C, Jones IR, McIntosh AM, Smith DJ, Walters JTR, Bradley JR, Kingston N, Ashford S, Beange I, Brailean A, Cleare AJ, Coleman JRI, Curtis CJ, ... ... Young AH, et al. The Genetic Links to Anxiety and Depression (GLAD) Study: Online recruitment into the largest recontactable study of depression and anxiety. Behaviour Research and Therapy. 123: 103503. PMID 31715324 DOI: 10.1016/J.Brat.2019.103503 |
0.401 |
|
| 2019 |
Figaro-Drumond FV, Pereira SC, Menezes IC, von Werne Baes C, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MF, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research. 112343. PMID 31704233 DOI: 10.1016/j.bbr.2019.112343 |
0.358 |
|
| 2019 |
Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, Murru A, Solé E, Stubbs B, Carvalho AF, Serretti A, Vieta E, Fusar-Poli P, McGuire P, Young AH, et al. Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. The American Journal of Psychiatry. appiajp201919030228. PMID 31623458 DOI: 10.1176/Appi.Ajp.2019.19030228 |
0.33 |
|
| 2019 |
Tsapekos D, Seccomandi B, Mantingh T, Cella M, Wykes T, Young AH. Cognitive enhancement interventions for people with bipolar disorder: a systematic review of methodological quality, treatment approaches, and outcomes. Bipolar Disorders. PMID 31610086 DOI: 10.1111/bdi.12848 |
0.347 |
|
| 2019 |
Humpston C, Benedetti F, Serfaty M, Markham S, Hodsoll J, Young AH, Veale D. Chronotherapy for the rapid treatment of depression: A meta-analysis. Journal of Affective Disorders. 261: 91-102. PMID 31606606 DOI: 10.1016/j.jad.2019.09.078 |
0.313 |
|
| 2019 |
Anmella G, Gil-Badenes J, Pacchiarotti I, Verdolini N, Aedo A, Angst J, Azorin JM, Bowden CL, Mosolov S, Samalin L, Popovic D, Young AH, Perugi G, Vieta E, Murru A. "Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study". Journal of Affective Disorders. 261: 30-39. PMID 31600585 DOI: 10.1016/j.jad.2019.09.070 |
0.392 |
|
| 2019 |
Scott J, Hidalgo-Mazzei D, Strawbridge R, Young A, Resche-Rigon M, Etain B, Andreassen OA, Bauer M, Bennabi D, Blamire AM, Boumezbeur F, Brambilla P, Cattane N, Cattaneo A, Chupin M, et al. Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative. International Journal of Bipolar Disorders. 7: 20. PMID 31552554 DOI: 10.1186/S40345-019-0156-X |
0.389 |
|
| 2019 |
Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH. First episode mania: we should have intervened earlier. The Lancet. Psychiatry. 6: 807-808. PMID 31544759 DOI: 10.1016/S2215-0366(19)30340-2 |
0.337 |
|
| 2019 |
Zahn R, Weingartner JH, Basilio R, Bado P, Mattos P, Sato JR, de Oliveira-Souza R, Fontenelle LF, Young AH, Moll J. Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trial. Neuroimage. Clinical. 24: 101992. PMID 31505367 DOI: 10.1016/J.Nicl.2019.101992 |
0.34 |
|
| 2019 |
Lombardo G, Enache D, Gianotti L, Schatzberg AF, Young AH, Pariante CM, Mondelli V. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis. Psychoneuroendocrinology. 110: 104420. PMID 31499391 DOI: 10.1016/J.Psyneuen.2019.104420 |
0.43 |
|
| 2019 |
Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, ... ... Young AH, et al. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disorders. PMID 31491048 DOI: 10.1111/Bdi.12834 |
0.333 |
|
| 2019 |
Qureshi MM, Young AH. The Chimera of Circular Insanity and the labours of Thyreoidea. Bipolar Disorders. PMID 31491040 DOI: 10.1111/bdi.12833 |
0.318 |
|
| 2019 |
Barbuti M, Mainardi C, Pacchiarotti I, Verdolini N, Maccariello G, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Perugi G. The role of different patterns of psychomotor symptoms in major depressive episode: pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. Bipolar Disorders. PMID 31400256 DOI: 10.1111/bdi.12816 |
0.391 |
|
| 2019 |
Agustini B, Bocharova M, Walker AJ, Berk M, Young AH, Juruena MF. Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects. Journal of Affective Disorders. 256: 584-593. PMID 31299439 DOI: 10.1016/J.Jad.2019.06.060 |
0.427 |
|
| 2019 |
Nikolova V, Zaidi SY, Young AH, Cleare AJ, Stone JM. Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 9: 2045125319859963. PMID 31263542 DOI: 10.1177/2045125319859963 |
0.398 |
|
| 2019 |
Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH. The case for improved care and provision of treatment for people with first-episode mania. The Lancet. Psychiatry. PMID 31248840 DOI: 10.1016/S2215-0366(19)30082-3 |
0.334 |
|
| 2019 |
Perugi G, Pacchiarotti I, Mainardi C, Verdolini N, Menculini G, Barbuti M, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31227264 DOI: 10.1016/j.euroneuro.2019.06.001 |
0.442 |
|
| 2019 |
Barbuti M, Mazzarini L, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. Journal of Affective Disorders. 256: 250-258. PMID 31195243 DOI: 10.1016/j.jad.2019.06.005 |
0.466 |
|
| 2019 |
Brancati GE, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state? Journal of Psychiatric Research. 115: 151-157. PMID 31132693 DOI: 10.1016/j.jpsychires.2019.05.014 |
0.366 |
|
| 2019 |
Valli I, Fabbri C, Young AH. Uncovering neurodevelopmental features in bipolar affective disorder. The British Journal of Psychiatry : the Journal of Mental Science. 1-3. PMID 31113507 DOI: 10.1192/bjp.2019.117 |
0.405 |
|
| 2019 |
Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini R, Severus E. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disorders. PMID 31112628 DOI: 10.1111/Bdi.12805 |
0.371 |
|
| 2019 |
Husain MI, Strawbridge R, Carter B, Jones BDM, Young A, Carvalho AF. Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta-analysis. Bmj Open. 9: e028538. PMID 31092667 DOI: 10.1136/Bmjopen-2018-028538 |
0.397 |
|
| 2019 |
Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Young AH, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/S41588-019-0397-8 |
0.385 |
|
| 2019 |
Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. Bmj (Clinical Research Ed.). 364: l1079. PMID 30917990 DOI: 10.1136/Bmj.L1079 |
0.345 |
|
| 2019 |
Jauhar S, Young AH. Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. International Journal of Bipolar Disorders. 7: 10. PMID 30915592 DOI: 10.1186/s40345-019-0145-0 |
0.401 |
|
| 2019 |
King S, Jelen LA, Horne CM, Cleare A, Pariante CM, Young AH, Stone JM. Inflammation, Glutamate, and Cognition in Bipolar Disorder Type II: A Proof of Concept Study. Frontiers in Psychiatry. 10: 66. PMID 30881316 DOI: 10.3389/Fpsyt.2019.00066 |
0.334 |
|
| 2019 |
King S, Stone JM, Cleare A, Young AH. A systematic review on neuropsychological function in bipolar disorders type I and II and subthreshold bipolar disorders-something to think about. Cns Spectrums. 24: 127-143. PMID 30859934 DOI: 10.1017/S1092852918001463 |
0.418 |
|
| 2019 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, Hamish McAllister-Williams R, Morriss R, ... ... Young AH, et al. Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 30816078 DOI: 10.1192/Bjp.2019.36 |
0.336 |
|
| 2019 |
Verdolini N, Menculini G, Perugi G, Murru A, Samalin L, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Barbuti M, Popovic D, Vieta E, Pacchiarotti I. Sultans of Swing: A Reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a Post Hoc Analysis of the BRIDGE-II-MIX Study. The Journal of Clinical Psychiatry. 80. PMID 30786180 DOI: 10.4088/JCP.17m12082 |
0.364 |
|
| 2019 |
Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, et al. Associations between childhood maltreatment and inflammatory markers. Bjpsych Open. 5: e3. PMID 30762500 DOI: 10.1192/Bjo.2018.80 |
0.376 |
|
| 2019 |
Palacios J, Yildiz A, Young AH, Taylor MJ. Tamoxifen for bipolar disorder: Systematic review and meta-analysis. Journal of Psychopharmacology (Oxford, England). 269881118822167. PMID 30741085 DOI: 10.1177/0269881118822167 |
0.405 |
|
| 2019 |
Burdick KE, Millett CE, Del Mar Bonnín C, Bowie C, Carvalho AF, Eyler LT, Gallagher P, Harvey P, Kessing LV, Lafer B, Langenecker SA, Lewandowski KE, López-Jaramillo C, Marshall DF, Martinez-Aran A, ... ... Young A, et al. The International Consortium Investigating Neurocognition in Bipolar Disorder (ICONIC-BD). Bipolar Disorders. PMID 30720913 DOI: 10.1111/Bdi.12748 |
0.39 |
|
| 2019 |
McIntyre RS, Anderson N, Baune BT, Brietzke E, Burdick K, Fossati P, Gorwood P, Harmer C, Harrison J, Harvey P, Mansur RB, Medalia A, Miskowiak K, Ramey T, Rong C, ... ... Young A, et al. Expert Consensus on Screening and Assessment of Cognition in Psychiatry. Cns Spectrums. 1-9. PMID 30642417 DOI: 10.1017/S1092852918001189 |
0.366 |
|
| 2019 |
Wolke SA, Mehta MA, O'Daly O, Zelaya F, Zahreddine N, Keren H, O'Callaghan G, Young A, Leibenluft E, Pine DS, Stringaris A. Modulation of anterior cingulate cortex reward and penalty signalling in medication-naive young-adult subjects with depressive symptoms following acute dose lurasidone. Psychological Medicine. 1-13. PMID 30606271 DOI: 10.1017/S0033291718003306 |
0.345 |
|
| 2019 |
King S, Jelen L, Pariante CM, Cleare AJ, Young AH, Stone JM. Glutamate, inflammation, and cognition as predictors of psychological therapy outcome in bipolar disorder II Psychoneuroendocrinology. 100. DOI: 10.1016/J.Psyneuen.2018.12.188 |
0.33 |
|
| 2019 |
Zahn R, Jaeckle T, Williams S, Barker G, Young A, Basilio R, Moll J. The future role of fMRI neurofeedback in depression treatment and research Journal of Affective Disorders. 254: 156-157. DOI: 10.1016/J.Jad.2018.10.354 |
0.364 |
|
| 2019 |
Strawbridge R, Young AH, Cleare AJ. Treatment-resistant depression: a possible 'inflammatory subtype' of depressive disorder Journal of Affective Disorders. 254: 152-153. DOI: 10.1016/J.Jad.2018.10.343 |
0.425 |
|
| 2019 |
Herane-Vives A, Arnone D, Saint-Pierre C, Aguirre J, Fischer S, Tsapekos D, Angel Vd, Papadopoulos A, Wise T, Young AH, Cleare AJ. Simultaneous assessment of cortisol levels in saliva, hair and fingernail specimens in depressive and healthy people Journal of Affective Disorders. 254: 152. DOI: 10.1016/J.Jad.2018.10.342 |
0.355 |
|
| 2019 |
Strawbridge R, Hidalgo-Mazzei D, Young AH, Mazzei FB. Optimising response to lithium treatment through personalised evaluation of individuals with bipolar I disorder: the R-LiNK study Journal of Affective Disorders. 254: 151. DOI: 10.1016/J.Jad.2018.10.339 |
0.364 |
|
| 2019 |
Tsapekos D, Mantingh T, Strawbridge R, Young AH. An exploration of goal-setting for Cognitive Remediation Therapy in patients with bipolar disorder Journal of Affective Disorders. 254: 145-146. DOI: 10.1016/J.Jad.2018.10.324 |
0.356 |
|
| 2019 |
Nikolova V, Hidalgo-Mazzei D, Young AH, Vieta E, Colom F. Age as predictor of retention in a smartphone-based psychoeducation programme for bipolar disorder (OpenSIMPLe) Journal of Affective Disorders. 254: 145. DOI: 10.1016/J.Jad.2018.10.322 |
0.372 |
|
| 2019 |
Nikolova V, Zaidi SY, Young AH, Stone J. Gut feeling: Systematic Review of Randomised Controlled Trials of Probiotics for the Treatment of Clinical Depression Journal of Affective Disorders. 254: 144. DOI: 10.1016/J.Jad.2018.10.320 |
0.354 |
|
| 2019 |
Mantingh T, Tsapekos D, Strawbridge R, Hodsoll J, Macritchie K, Stokes P, Wykes T, Young A. Impact of subthreshold symptoms on cognitive performance in patients with bipolar disorder Journal of Affective Disorders. 254: 130-131. DOI: 10.1016/J.Jad.2018.10.286 |
0.377 |
|
| 2019 |
Herane-Vives A, Young AH, Wise T, Aguirre J, Angel Vd, Arnone D, Tsapekos D, Papadopoulos A, Cleare AJ. A comparison of short- and long-term cortisol levels in melancholic and non-melancholic major depressive episodes using hair and saliva specimens Journal of Affective Disorders. 254: 127-128. DOI: 10.1016/J.Jad.2018.10.278 |
0.332 |
|
| 2019 |
Anmella G, Corponi F, Pacchiarotti I, Verdolini N, Samalin L, Popovic D, Azorin J, Angst J, Bowden C, Mosolov S, Young A, Perugi G, Vieta E, Serretti A, Murru A. P.612 Symptom network structure differences in acute depression between bipolar disorder and major depressive disorder: A network analysis. European Neuropsychopharmacology. 29: S419-S420. DOI: 10.1016/j.euroneuro.2019.09.596 |
0.312 |
|
| 2019 |
Mainardi C, Pacchiarotti I, Verdolini N, Barbuti M, Maccariello G, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Perugi G. Psychomotor symptoms in major depressive episode are related to bipolarity. A pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.547 |
0.375 |
|
| 2019 |
Murru A, Guiso G, Barbuti M, Verdolini N, Samalin L, Azorin J, Angst J, Bowden C, Sergey M, Young A, Popovic D, Valdes M, Perugi G, Vieta E, Pacchiarotti I. Hypersomnia as an objective clinical biomarker and prognostic indicator in depressed patients: A post-hoc analysis from the BRIDGE-II- MIX Study European Neuropsychopharmacology. 29: S350-S351. DOI: 10.1016/J.Euroneuro.2018.11.543 |
0.342 |
|
| 2019 |
Anmella G, Verdolini N, Pacchiarotti I, Aedo A, Angst J, Azorin J, Bowden C, Mosolov S, Samalin L, Popovic D, Young A, Perugi G, Vieta E, Murru A. The differential role of depressive and manic symptoms in predicting functioning outcome in major depression: A BRIDGE-Mix-II post-hoc analysis European Neuropsychopharmacology. 29: S74-S75. DOI: 10.1016/j.euroneuro.2018.11.1054 |
0.358 |
|
| 2019 |
Wajs E, Leah A, Morrison R, Daly E, Lane R, Lim P, Holder R, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, et al. Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1016 |
0.333 |
|
| 2019 |
Verdolini N, Menculini G, Perugi G, Murru A, Samalin L, Angst J, Azorin J, Bowden C, Mosolov S, Young A, Barbuti M, Popovic D, Vieta E, Pacchiarotti I. Affective lability as a mixed symptom: Investigating its association with mood reactivity during a major depressive episode European Neuropsychopharmacology. 29: S42-S43. DOI: 10.1016/j.euroneuro.2018.11.1014 |
0.383 |
|
| 2019 |
Palmos A, Watson S, Young AH, Strawbridge R, Cleare AJ, Chung R, Hotopf M, Wang H, Collier DA, Thuret S, Breen G, Powell TR. Are Some Maltreated Individuals 'Immune' To Later Life Depression? An Investigation Of 41 Inflammatory Markers In Over 600 U.K. Adults European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.115 |
0.364 |
|
| 2018 |
Vannucchi G, Medda P, Pallucchini A, Bertelli M, Angst J, Azorin JM, Bowden C, Vieta E, Young AH, Mosolov S, Perugi G. The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study. Journal of Affective Disorders. 246: 346-354. PMID 30597295 DOI: 10.1016/j.jad.2018.12.089 |
0.302 |
|
| 2018 |
Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 30566398 DOI: 10.1192/bjp.2018.291 |
0.34 |
|
| 2018 |
Jelen LA, King S, Horne CM, Lythgoe DJ, Young AH, Stone JM. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30558824 DOI: 10.1016/j.euroneuro.2018.12.005 |
0.313 |
|
| 2018 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, ... ... Young AH, et al. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 30520709 DOI: 10.1192/Bjp.2018.257 |
0.44 |
|
| 2018 |
McAllister-Williams RH, Christmas DMB, Cleare AJ, Currie A, Gledhill J, Insole L, Malizia AL, McGeever M, Morriss R, Robinson LJ, Scott M, Stokes PRA, Talbot PS, Young AH. Multiple-therapy-resistant major depressive disorder: a clinically important concept. The British Journal of Psychiatry : the Journal of Mental Science. 212: 274-278. PMID 30517072 DOI: 10.1192/bjp.2017.33 |
0.329 |
|
| 2018 |
Macritchie K, Mantingh T, Hidalgo-Mazzei D, Bourne S, Borthwick E, Young AH. A new inner-city specialist programme reduces readmission rates in frequently admitted patients with bipolar disorder. Bjpsych Bulletin. 1-3. PMID 30481491 DOI: 10.1192/bjb.2018.89 |
0.361 |
|
| 2018 |
Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 1-10. PMID 30457075 DOI: 10.1192/bjp.2018.233 |
0.37 |
|
| 2018 |
Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, ... ... Young AH, et al. Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. The Australian and New Zealand Journal of Psychiatry. 4867418808382. PMID 30378461 DOI: 10.1177/0004867418808382 |
0.375 |
|
| 2018 |
Fischer S, King S, Papadopoulos A, Hotopf M, Young AH, Cleare AJ. Hair cortisol and childhood trauma predict psychological therapy response in depression and anxiety disorders. Acta Psychiatrica Scandinavica. PMID 30302747 DOI: 10.1111/Acps.12970 |
0.437 |
|
| 2018 |
Pisoni A, Strawbridge R, Hodsoll J, Powell TR, Breen G, Hatch S, Hotopf M, Young AH, Cleare AJ. Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision. Frontiers in Psychiatry. 9: 386. PMID 30190686 DOI: 10.3389/fpsyt.2018.00386 |
0.37 |
|
| 2018 |
Hidalgo-Mazzei D, Reinares M, Mateu A, Nikolova VL, Bonnín CDM, Samalin L, García-Estela A, Pérez-Solá V, Young AH, Strejilevich S, Vieta E, Colom F. OpenSIMPLe: A real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder. Journal of Affective Disorders. 241: 436-445. PMID 30145515 DOI: 10.1016/j.jad.2018.08.048 |
0.338 |
|
| 2018 |
McIntyre RS, Young AH, Haddad PM. Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France. Therapeutic Advances in Psychopharmacology. 8: 1-16. PMID 29977518 DOI: 10.1177/2045125318762911 |
0.458 |
|
| 2018 |
Verdolini N, Hidalgo-Mazzei D, Murru A, Pacchiarotti I, Samalin L, Young AH, Vieta E, Carvalho AF. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatrica Scandinavica. PMID 29756288 DOI: 10.1111/acps.12896 |
0.387 |
|
| 2018 |
Hidalgo-Mazzei D, Young AH, Vieta E, Colom F. Behavioural biomarkers and mobile mental health: a new paradigm. International Journal of Bipolar Disorders. 6: 9. PMID 29730832 DOI: 10.1186/s40345-018-0119-7 |
0.306 |
|
| 2018 |
Mazer AK, Cleare AJ, Young AH, Juruena MF. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures. Behavioural Brain Research. PMID 29702176 DOI: 10.1016/j.bbr.2018.04.015 |
0.38 |
|
| 2018 |
Wise T, Marwood L, Perkins AM, Herane-Vives A, Williams SCR, Young AH, Cleare AJ, Arnone D. A morphometric signature of depressive symptoms in unmedicated patients with mood disorders. Acta Psychiatrica Scandinavica. PMID 29682732 DOI: 10.1111/Acps.12887 |
0.391 |
|
| 2018 |
Nikolova VL, Pattanaseri K, Hidalgo-Mazzei D, Taylor D, Young AH. Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting. Journal of Psychopharmacology (Oxford, England). 269881118760663. PMID 29552933 DOI: 10.1177/0269881118760663 |
0.333 |
|
| 2018 |
Wise T, Taylor MJ, Herane-Vives A, Gammazza AM, Cappello F, Lythgoe DJ, Williams SC, Young AH, Cleare AJ, Arnone D. Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase. Journal of Affective Disorders. 234: 214-219. PMID 29544167 DOI: 10.1016/j.jad.2018.02.059 |
0.441 |
|
| 2018 |
Heslin M, Young AH. Psychotic major depression: challenges in clinical practice and research. The British Journal of Psychiatry : the Journal of Mental Science. 212: 131-133. PMID 29486823 DOI: 10.1192/bjp.2017.43 |
0.41 |
|
| 2018 |
Roberts E, Carter B, Young AH. Caveat emptor: Folate in unipolar depressive illness, a systematic review and meta-analysis. Journal of Psychopharmacology (Oxford, England). 269881118756060. PMID 29442609 DOI: 10.1177/0269881118756060 |
0.441 |
|
| 2018 |
Herane-Vives A, de Angel V, Papadopoulos A, Wise T, Chua KC, Strawbridge R, Castillo D, Arnone D, Young AH, Cleare AJ. Short-term and long-term measures of cortisol in saliva and hair in atypical and non-atypical depression. Acta Psychiatrica Scandinavica. PMID 29397570 DOI: 10.1111/acps.12852 |
0.367 |
|
| 2018 |
Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, ... ... Young AH, et al. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disorders. PMID 29345040 DOI: 10.1111/Bdi.12595 |
0.353 |
|
| 2018 |
Douglas KM, Gallagher P, Robinson LJ, Carter JD, McIntosh VV, Frampton CM, Watson S, Young AH, Ferrier IN, Porter RJ. Prevalence of cognitive impairment in major depression and bipolar disorder. Bipolar Disorders. PMID 29345037 DOI: 10.1111/bdi.12602 |
0.405 |
|
| 2018 |
Mazzarini L, Kotzalidis GD, Piacentino D, Rizzato S, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Girardi P, Perugi G. Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study. Journal of Affective Disorders. 229: 164-170. PMID 29310066 DOI: 10.1016/j.jad.2017.12.062 |
0.435 |
|
| 2018 |
O'Callaghan G, Wolke S, Kaiser A, Mehta M, Young A, Winkler A, Pine DS, Stringaris A. F176. A Randomized, Double-Blind, Placebo-Controlled-Crossover Design Investigating the Impact of a Pharmacological Challenge on Neural Mechanisms of Response Inhibition in Depression Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.790 |
0.315 |
|
| 2017 |
Herane-Vives A, Fischer S, de Angel V, Wise T, Cheung E, Chua KC, Arnone D, Young AH, Cleare AJ. Elevated fingernail cortisol levels in major depressive episodes. Psychoneuroendocrinology. 88: 17-23. PMID 29153629 DOI: 10.1016/J.Psyneuen.2017.10.026 |
0.384 |
|
| 2017 |
Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. Journal of Affective Disorders. PMID 29150144 DOI: 10.1016/j.jad.2017.09.052 |
0.384 |
|
| 2017 |
Suppes T, Eberhard J, Lemming O, Young AH, McIntyre RS. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials. International Journal of Bipolar Disorders. 5: 36. PMID 29105003 DOI: 10.1186/S40345-017-0103-7 |
0.418 |
|
| 2017 |
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia. Jama Psychiatry. PMID 29049482 DOI: 10.1001/Jamapsychiatry.2017.2943 |
0.339 |
|
| 2017 |
Kapila A, Fisher HL, Johnson S, Major B, Rahaman N, Joyce J, Chamberlain-Kent N, Lawrence J, Young AH, Stone JM. Clinical and demographic differences between patients with manic, depressive and schizophrenia-spectrum psychoses presenting to Early Intervention Services in London. Early Intervention in Psychiatry. PMID 29034588 DOI: 10.1111/eip.12511 |
0.334 |
|
| 2017 |
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-19. PMID 28984491 DOI: 10.1080/15622975.2017.1379609 |
0.431 |
|
| 2017 |
Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Torres IJ, Yatham LN, ... Young AH, et al. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disorders. PMID 28895274 DOI: 10.1111/Bdi.12534 |
0.38 |
|
| 2017 |
Stokes PRA, Kalk NJ, Young AH. Bipolar disorder and addictions: the elephant in the room. The British Journal of Psychiatry : the Journal of Mental Science. 211: 132-134. PMID 28864753 DOI: 10.1192/bjp.bp.116.193912 |
0.419 |
|
| 2017 |
Husain MI, Strawbridge R, Stokes PR, Young AH. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis. Journal of Psychopharmacology (Oxford, England). 269881117725711. PMID 28858537 DOI: 10.1177/0269881117725711 |
0.364 |
|
| 2017 |
Husain MI, Chaudhry IB, Husain N, Khoso AB, Rahman RR, Hamirani MM, Hodsoll J, Qurashi I, Deakin JF, Young AH. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial. Journal of Psychopharmacology (Oxford, England). 269881117724352. PMID 28857658 DOI: 10.1177/0269881117724352 |
0.377 |
|
| 2017 |
Verdolini N, Perugi G, Samalin L, Murru A, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Barbuti M, Guiso G, Popovic D, Vieta E, Pacchiarotti I. Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features. Acta Psychiatrica Scandinavica. PMID 28741646 DOI: 10.1111/acps.12777 |
0.445 |
|
| 2017 |
Hidalgo-Mazzei D, Reinares M, Mateu A, Juruena MF, Young AH, Pérez-Sola V, Vieta E, Colom F. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder? Journal of Affective Disorders. 223: 10-16. PMID 28711743 DOI: 10.1016/j.jad.2017.07.028 |
0.376 |
|
| 2017 |
Petri E, Bacci O, Barbuti M, Pacchiarotti I, Azorin JM, Angst J, Bowden CL, Mosolov S, Vieta E, Young AH, Perugi G. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study. Bipolar Disorders. PMID 28691250 DOI: 10.1111/bdi.12519 |
0.389 |
|
| 2017 |
Marwood L, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ. Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study). Bmc Psychiatry. 17: 231. PMID 28651526 DOI: 10.1186/s12888-017-1393-0 |
0.402 |
|
| 2017 |
Young AH. Lithium for long-term treatment of unipolar depression. The Lancet. Psychiatry. PMID 28578902 DOI: 10.1016/S2215-0366(17)30232-8 |
0.35 |
|
| 2017 |
Barbuti M, Pacchiarotti I, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study. Journal of Affective Disorders. 219: 187-192. PMID 28558366 DOI: 10.1016/j.jad.2017.05.035 |
0.429 |
|
| 2017 |
Kalk NJ, Young AH. Footnotes to Kraepelin: changes in the classification of mood disorders with DSM-5. Bjpsych Open. 3: e1-e3. PMID 28507774 DOI: 10.1192/bjpo.bp.117.004739 |
0.446 |
|
| 2017 |
Young AH, Evitt L, Brignone M, Diamand F, Atsou K, Campbell R, Cure S, Danchenko N. Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom. Journal of Affective Disorders. 218: 291-298. PMID 28478358 DOI: 10.1016/J.Jad.2017.04.019 |
0.419 |
|
| 2017 |
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Young AH, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73 |
0.335 |
|
| 2017 |
McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH. Erratum to "Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists" [J. Affect. Disord. 207 (2017) 346-352]. Journal of Affective Disorders. 217: 306-307. PMID 28456050 DOI: 10.1016/j.jad.2017.04.023 |
0.338 |
|
| 2017 |
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, ... ... Young A, et al. Guidelines for the recognition and management of mixed depression. Cns Spectrums. 1-17. PMID 28421980 DOI: 10.1017/S1092852917000165 |
0.408 |
|
| 2017 |
Cuomo A, Nikolova VL, Yalin N, Arnone D, Fagiolini A, Young AH. Pharmacological treatment of mixed states. Cns Spectrums. 1-10. PMID 28416033 DOI: 10.1017/S1092852917000013 |
0.389 |
|
| 2017 |
Bauer M, Severus E, Möller HJ, Young AH. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines. International Journal of Psychiatry in Clinical Practice. 1-11. PMID 28367707 DOI: 10.1080/13651501.2017.1306082 |
0.476 |
|
| 2017 |
Herane-Vives A, Cleare AJ, Chang CK, de Angel V, Papadopoulos A, Fischer S, Halari R, Cheung EY, Young AH. Cortisol levels in fingernails, neurocognitive performance and clinical variables in euthymic bipolar I disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-12. PMID 28345388 DOI: 10.1080/15622975.2017.1298838 |
0.391 |
|
| 2017 |
Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, Howes OD. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Molecular Psychiatry. PMID 28289283 DOI: 10.1038/Mp.2017.16 |
0.399 |
|
| 2017 |
Juruena MF, Agustini B, Cleare AJ, Young AH. A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling. Stem Cell Investigation. 4: 13. PMID 28275643 DOI: 10.21037/sci.2017.02.01 |
0.325 |
|
| 2017 |
O'Hagan M, Cornelius V, Young AH, Taylor D. Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorder. International Clinical Psychopharmacology. PMID 28207568 DOI: 10.1097/YIC.0000000000000163 |
0.345 |
|
| 2017 |
Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Mehmood N, Haddad PM, Hodsoll J, Young AH, Naeem F, Husain N. Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan. International Journal of Bipolar Disorders. 5: 3. PMID 28155203 DOI: 10.1186/s40345-017-0074-8 |
0.391 |
|
| 2017 |
Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JF, Husain N, Young AH. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial. Neuropsychiatric Disease and Treatment. 13: 1-8. PMID 28031712 DOI: 10.2147/NDT.S115002 |
0.429 |
|
| 2017 |
Agustini B, Bocharova M, Young A, Juruena M. Seasonal Affective Disorder and HPA axis function: A Systematic Review. Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00036 |
0.364 |
|
| 2017 |
Patrick F, Wise T, Meyer N, Mazibuko N, Oates A, Van Der Bijl A, Danjou P, O'Connor S, Doolin E, Wooldridge C, Macare C, Williams S, Perkins A, Young A. Modulation of Anxiety-Relevant Neural Circuits in Generalized Anxiety Disorder: A Novel Cholinergic System Pharmacotherapy Approach. Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00033 |
0.341 |
|
| 2017 |
Macritchie K, Borthwick E, Bourne S, Hidalgo-Mazzei D, Mantingh T, Young A. The OPTIMA Core Programme: early audit findings on the effectiveness of an inner-city specialist service for frequently admitted patients with bipolar disorder Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00024 |
0.355 |
|
| 2017 |
Herane A, Wise T, Angel VD, Arnone D, Tsapekos D, Papadopoulos A, Young A, Cleare A. Cortisol levels in typical and non-typical major depressive episodes, using hair and saliva specimens Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00022 |
0.367 |
|
| 2017 |
Patrick F, Higgins-Stockden F, Young A, Young A, Perkins A. Using an online personality questionnaire for rapid recruitment of hard to find participants in affective disorders research. Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00020 |
0.333 |
|
| 2017 |
Juruena M, Tursi MFD, Hidalgo-Mazzei D, Young A. Effectiveness of Psychoeducation for Patients with Unipolar Depression Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00017 |
0.378 |
|
| 2017 |
Juruena M, Castro M, Graeff F, Cleare A, Young A. Mineralocorticoid Receptor Agonist as a Predictor of Treatment Outcome in Depression with and without Early Life Stress Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00013 |
0.316 |
|
| 2017 |
Bocharova M, Agustini B, Young A, Juruena M. HPA Axis Function as Biomarker for Atypical and Melancholic Depression Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00006 |
0.355 |
|
| 2017 |
Verdolini N, Perugi G, Samalin L, Murru A, Angst J, Azorin J, Bowden C, Mosolov S, Young A, Barbuti M, Guiso G, Popovic D, Vieta E, Pacchiarotti I. Is aggression a missed bipolar diagnostic feature in mixed depression? European Neuropsychopharmacology. 27: S876-S877. DOI: 10.1016/S0924-977X(17)31569-9 |
0.383 |
|
| 2017 |
Barbuti M, Pacchiarotti I, Azorin JM, Angst J, Bowden CL, Mosolov S, Vieta E, Young AH, Perugi G. Antidepressant-induced hypomania in patients with major depression: evidence from the BRIDGE-II-MIX study European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)30126-8 |
0.371 |
|
| 2017 |
Fischer S, King S, Papadopoulos A, Hotopf M, Young AH, Cleare AJ. Hair cortisol as predictor of psychotherapy response in affective disorders Psychoneuroendocrinology. 83: 46. DOI: 10.1016/J.Psyneuen.2017.07.364 |
0.374 |
|
| 2017 |
Vives AH, Wise T, Angel VD, Arnone D, Tsapekos D, Papadopoulos A, Young A, Cleare A. Cortisol levels in typical and non-typical major depressive episodes, using hair and saliva specimens Psychoneuroendocrinology. 83: 44-45. DOI: 10.1016/J.Psyneuen.2017.07.359 |
0.367 |
|
| 2017 |
Wise T, Marwood L, Adam P, Herane-Vives A, Williams S, Young A, Cleare A, Arnone D. 265. Morphometric Correlates of Bipolarity in Major Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.279 |
0.399 |
|
| 2017 |
Young A, Patrick F, Wise T, Meyer N, Mazibuko N, Oates AE, Bijl AMHvd, Danjou P, O’Connor S, Doolin E, Wooldridge C, Macare C, Williams SC, Perkins A, Young AH. 169 - Modulation of Anxiety-Relevant Neural Circuits in Generalized Anxiety Disorder: A Novel Cholinergic System Pharmacotherapy Approach Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.182 |
0.341 |
|
| 2016 |
Bosaipo NB, Foss MP, Young AH, Juruena MF. Neuropsychological Changes in Melancholic and Atypical Depression: A Systematic Review. Neuroscience and Biobehavioral Reviews. PMID 28027956 DOI: 10.1016/j.neubiorev.2016.12.014 |
0.39 |
|
| 2016 |
Etain B, Lajnef M, Brichant-Petitjean C, Geoffroy PA, Henry C, Gard S, Kahn JP, Leboyer M, Young AH, Bellivier F. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders. Acta Psychiatrica Scandinavica. PMID 27987204 DOI: 10.1111/acps.12684 |
0.372 |
|
| 2016 |
Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. The International Journal of Neuropsychopharmacology. PMID 27941079 DOI: 10.1093/Ijnp/Pyw109 |
0.395 |
|
| 2016 |
Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. Psychedelics in the treatment of unipolar mood disorders: a systematic review. Journal of Psychopharmacology (Oxford, England). PMID 27856684 DOI: 10.1177/0269881116679368 |
0.49 |
|
| 2016 |
Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. The International Journal of Neuropsychopharmacology. PMID 27816941 DOI: 10.1093/Ijnp/Pyw100 |
0.34 |
|
| 2016 |
Fountoulakis KN, Young A, Yatham L, Grunze H, Vieta E, Blier P, Moeller HJ, Kasper S. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines. The International Journal of Neuropsychopharmacology. PMID 27815414 DOI: 10.1093/Ijnp/Pyw091 |
0.409 |
|
| 2016 |
McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH. Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists. Journal of Affective Disorders. 207: 346-352. PMID 27743537 DOI: 10.1016/j.jad.2016.09.036 |
0.362 |
|
| 2016 |
Galizia I, Oldani L, Macritchie K, Amari E, Dougall D, Jones TN, Lam RW, Massei GJ, Yatham LN, Young AH. S-adenosyl methionine (SAMe) for depression in adults. The Cochrane Database of Systematic Reviews. 10: CD011286. PMID 27727432 DOI: 10.1002/14651858.CD011286.pub2 |
0.364 |
|
| 2016 |
Young AH, Colasanti A. Carving depression at its joints? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 15: 239-241. PMID 27717264 DOI: 10.1002/wps.20367 |
0.33 |
|
| 2016 |
Fountoulakis KN, Vieta E, Young A, Yatham L, Grunze H, Blier P, Moeller HJ, Kasper S. The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: Unmet needs in the treatment of Bipolar disorder and recommendations for future research. The International Journal of Neuropsychopharmacology. PMID 27677983 DOI: 10.1093/Ijnp/Pyw072 |
0.412 |
|
| 2016 |
Pigott K, Galizia I, Vasudev K, Watson S, Geddes J, Young AH. Topiramate for acute affective episodes in bipolar disorder in adults. The Cochrane Database of Systematic Reviews. 9: CD003384. PMID 27591453 DOI: 10.1002/14651858.CD003384.pub3 |
0.422 |
|
| 2016 |
Strawbridge R, Fish J, Halari R, Hodsoll J, Reeder C, Macritchie K, McCrone P, Wykes T, Young AH. The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial. Trials. 17: 371. PMID 27472964 DOI: 10.1186/s13063-016-1472-4 |
0.372 |
|
| 2016 |
Yang H, Li L, Peng H, Liu T, Young AH, Angst J, Ye R, Rong H, Ji E, Qiu Y, Li L. Alterations in regional homogeneity of resting-state brain activity in patients with major depressive disorder screening positive on the 32-item hypomania checklist (HCL-32). Journal of Affective Disorders. 203: 69-76. PMID 27280965 DOI: 10.1016/j.jad.2016.05.004 |
0.418 |
|
| 2016 |
Fairbrother N, Janssen P, Antony MM, Tucker E, Young AH. Perinatal anxiety disorder prevalence and incidence. Journal of Affective Disorders. 200: 148-155. PMID 27131505 DOI: 10.1016/J.Jad.2015.12.082 |
0.309 |
|
| 2016 |
Osório C, Probert T, Jones E, Young AH, Robbins I. Adapting to stress: understanding the neurobiology of resilience. Behavioral Medicine (Washington, D.C.). 0. PMID 27100966 DOI: 10.1080/08964289.2016.1170661 |
0.342 |
|
| 2016 |
Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S, Hunt N, Jones I, ... ... Young AH, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology (Oxford, England). PMID 26979387 DOI: 10.1177/0269881116636545 |
0.392 |
|
| 2016 |
Wong JJ, O'Daly O, Mehta MA, Young AH, Stone JM. Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression? Peerj. 4: e1710. PMID 26925332 DOI: 10.7717/peerj.1710 |
0.304 |
|
| 2016 |
Hepgul N, King S, Amarasinghe M, Breen G, Grant N, Grey N, Hotopf M, Moran P, Pariante CM, Tylee A, Wingrove J, Young AH, Cleare AJ. Clinical characteristics of patients assessed within an Improving Access to Psychological Therapies (IAPT) service: results from a naturalistic cohort study (Predicting Outcome Following Psychological Therapy; PROMPT). Bmc Psychiatry. 16: 52. PMID 26920578 DOI: 10.1186/S12888-016-0736-6 |
0.349 |
|
| 2016 |
Wise T, Arnone D, Marwood L, Zahn R, Lythe KE, Young AH. Recruiting for research studies using online public advertisements: examples from research in affective disorders. Neuropsychiatric Disease and Treatment. 12: 279-85. PMID 26917961 DOI: 10.2147/Ndt.S90941 |
0.347 |
|
| 2016 |
Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Young AH, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/Mp.2015.227 |
0.344 |
|
| 2016 |
Malhi GS, Lingford-Hughes AR, Young AH. Antidepressant treatment response: 'I want it all, and I want it now!'†. The British Journal of Psychiatry : the Journal of Mental Science. 208: 101-3. PMID 26834163 DOI: 10.1192/bjp.bp.115.176479 |
0.348 |
|
| 2016 |
Vivekanantham S, Strawbridge R, Rampuri R, Ragunathan T, Young AH. Parity of publication for psychiatry. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26743809 DOI: 10.1192/bjp.bp.115.165118 |
0.343 |
|
| 2016 |
Popovic D, Torrent C, Vieta E, Azorin J, Angst J, Bowden C, Mosolov S, Young A, Perugi G. Hypomanic symptoms in mixed depression: is DSM-5 wrong? Evidence from the BRIDGE-II MIX study European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31409-2 |
0.347 |
|
| 2016 |
Young AH, Bones K, Goodwin GM, Harrison J, Katona C, McAllister-Williams RH, Rasmussen J, Strong S. Understanding cognitive dysfunction in depression in primary and secondary care in the UK: a multi-step consultation with clinicians European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31359-1 |
0.323 |
|
| 2016 |
Herane-Vives A, Chang C-, Papadopoulos A, Angel VD, Wise T, Chua C, Young AH, Cleare A. Long-term pattern of cortisol secretion in patients with depression, chronic fatigue syndrome and healthy controls Psychoneuroendocrinology. 71: 62. DOI: 10.1016/J.Psyneuen.2016.07.161 |
0.327 |
|
| 2016 |
Herane-Vives A, Angel VD, Wise T, Chang C, Papadopoulos A, Arnone D, Young A, Cleare A. Cortisol levels in unipolar and bipolar depression using hair and saliva specimens Psychoneuroendocrinology. 71: 21-22. DOI: 10.1016/J.Psyneuen.2016.07.063 |
0.389 |
|
| 2016 |
Herane-Vives A, Fischer S, Angel VD, Wise T, Papadopoulos A, Arnone D, Young A, Cleare A. Cortisol levels in major depressive episode using fingernail specimens Psychoneuroendocrinology. 71: 21. DOI: 10.1016/J.Psyneuen.2016.07.062 |
0.369 |
|
| 2016 |
Herane-Vives A, Angel VD, Chalder T, Soto L, Chua K, Young AH, Cleare A. Cortisol levels in atypical depression and chronic fatigue syndrome using hair and saliva specimens Psychoneuroendocrinology. 71: 21. DOI: 10.1016/J.Psyneuen.2016.07.061 |
0.329 |
|
| 2016 |
Herane-Vives A, Angel VD, Wise T, Chang C, Young AH, Arnone D, Cleare A. Cortisol levels in atypical and non-atypical depression using hair and saliva specimens Psychoneuroendocrinology. 71: 20. DOI: 10.1016/J.Psyneuen.2016.07.060 |
0.353 |
|
| 2016 |
Strawbridge R, Sartor M-, Young AH, Cleare AJ. Is chronic fatigue syndrome an inflammatory disorder Journal of Psychosomatic Research. 85: 82. DOI: 10.1016/J.Jpsychores.2016.03.203 |
0.315 |
|
| 2016 |
Popovic D, Torrent C, Vieta E, Azorin JM, Angst J, Mosolov S, Bowden CL, Young A. Hypomanic symptoms in mixed depression – is DSM-5 wrong? Evidence from the BRIDGE-II-MIX study European Psychiatry. 33. DOI: 10.1016/J.Eurpsy.2016.01.162 |
0.392 |
|
| 2016 |
Young AH, Bones K, Goodwin G, Harrison J, Katona C, McAllister-Williams H, Rasmussen J, Strong S. Consensus statements on cognitive dysfunction in depression in the UK: Rationale and process for gaining consensus European Psychiatry. 33. DOI: 10.1016/J.Eurpsy.2016.01.1537 |
0.393 |
|
| 2015 |
Lieblich SM, Castle DJ, Pantelis C, Hopwood M, Young AH, Everall IP. High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs. Bjpsych Open. 1: e5-e7. PMID 27703745 DOI: 10.1192/bjpo.bp.115.000786 |
0.395 |
|
| 2015 |
Wooderson SC, Gallagher P, Watson S, Young AH. An exploration of testosterone levels in patients with bipolar disorder. Bjpsych Open. 1: 136-138. PMID 27703738 DOI: 10.1192/Bjpo.Bp.115.001008 |
0.411 |
|
| 2015 |
Mitchell RL, Young AH. Theory of Mind in Bipolar Disorder, with Comparison to the Impairments Observed in Schizophrenia. Frontiers in Psychiatry. 6: 188. PMID 26834648 DOI: 10.3389/Fpsyt.2015.00188 |
0.388 |
|
| 2015 |
Colasanti A, Guo Q, Giannetti P, Wall MB, Newbould RD, Bishop C, Onega M, Nicholas R, Ciccarelli O, Muraro PA, Malik O, Owen DR, Young AH, Gunn RN, Piccini P, et al. Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis. Biological Psychiatry. PMID 26809249 DOI: 10.1016/J.Biopsych.2015.11.022 |
0.342 |
|
| 2015 |
Herane Vives A, De Angel V, Papadopoulos A, Strawbridge R, Wise T, Young AH, Arnone D, Cleare AJ. The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis. Journal of Psychiatric Research. 70: 38-49. PMID 26424422 DOI: 10.1016/j.jpsychires.2015.08.007 |
0.355 |
|
| 2015 |
Popovic D, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. Suicide attempts in major depressive episode: evidence from the BRIDGE-II-Mix study. Bipolar Disorders. PMID 26415692 DOI: 10.1111/bdi.12338 |
0.398 |
|
| 2015 |
Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Qurashi I, Khoso AB, Deakin JF, Husain N, Young AH. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial. Trials. 16: 410. PMID 26374703 DOI: 10.1186/s13063-015-0933-5 |
0.417 |
|
| 2015 |
Fagiolini A, Coluccia A, Maina G, Forgione RN, Goracci A, Cuomo A, Young AH. Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. Cns Drugs. PMID 26369921 DOI: 10.1007/s40263-015-0275-6 |
0.477 |
|
| 2015 |
Fairbrother N, Young AH, Janssen P, Antony MM, Tucker E. Depression and anxiety during the perinatal period. Bmc Psychiatry. 15: 206. PMID 26303960 DOI: 10.1186/S12888-015-0526-6 |
0.4 |
|
| 2015 |
Zahn R, Lythe KE, Gethin JA, Green S, Deakin JF, Young AH, Moll J. The role of self-blame and worthlessness in the psychopathology of major depressive disorder. Journal of Affective Disorders. 186: JADD1500334. PMID 26277271 DOI: 10.1016/J.Jad.2015.08.001 |
0.403 |
|
| 2015 |
Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P. WITHDRAWN: Antiglucocorticoid treatments for mood disorders. The Cochrane Database of Systematic Reviews. 6: CD005168. PMID 26098594 DOI: 10.1002/14651858.CD005168.pub3 |
0.412 |
|
| 2015 |
Perugi G, Angst J, Azorin JM, Bowden CL, Caciagli A, Mosolov S, Vieta E, Young AH. Relationships between mixed features and borderline personality disorder in 2811 patients with major depressive episode. Acta Psychiatrica Scandinavica. PMID 26073759 DOI: 10.1111/acps.12457 |
0.445 |
|
| 2015 |
Gallagher P, Nilsson J, Finkelmeyer A, Goshawk M, Macritchie KA, Lloyd AJ, Thompson JM, Porter RJ, Young AH, Ferrier IN, McAllister-Williams RH, Watson S. Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions. Psychological Medicine. 1-13. PMID 26073667 DOI: 10.1017/S0033291715000926 |
0.43 |
|
| 2015 |
Young AH, Eberhard J. Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder. Neuropsychiatric Disease and Treatment. 11: 1137-43. PMID 25995638 DOI: 10.2147/Ndt.S82532 |
0.464 |
|
| 2015 |
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology (Oxford, England). 29: 459-525. PMID 25969470 DOI: 10.1177/0269881115581093 |
0.433 |
|
| 2015 |
Wise T, Radua J, Nortje G, Cleare AJ, Young AH, Arnone D. Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder. Biological Psychiatry. PMID 25891219 DOI: 10.1016/J.Biopsych.2015.03.004 |
0.457 |
|
| 2015 |
Perugi G, Angst J, Azorin JM, Bowden CL, Mosolov S, Reis J, Vieta E, Young AH. Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. The Journal of Clinical Psychiatry. 76: e351-8. PMID 25830457 DOI: 10.4088/JCP.14m09092 |
0.455 |
|
| 2015 |
Husain I, Chaudhry IB, Rahman RR, Hamirani MM, Qurashi I, Khoso AB, Husain N, Young A. Minocycline as an adjunct for the treatment of depressive symptoms Bipolar Disorders. 17: 136-136. DOI: 10.1111/Bdi.12309 |
0.358 |
|
| 2015 |
Popovic D, Vieta E, Azorin J, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G. P.2.d.003 Suicidal behaviour in major depressive episode: evidence from the BRIDGE-II-MIX study European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30545-9 |
0.344 |
|
| 2014 |
Young AH. Lithium and suicide. The Lancet. Psychiatry. 1: 483-4. PMID 26361203 DOI: 10.1016/S2215-0366(14)70320-7 |
0.349 |
|
| 2014 |
Oldani L, Altamura AC, Abdelghani M, Young AH. Brain stimulation treatments in bipolar disorder: A review of the current literature. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-13. PMID 25471324 DOI: 10.3109/15622975.2014.984630 |
0.395 |
|
| 2014 |
Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A, Castle DJ. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey. Journal of Affective Disorders. 172: 30-37. PMID 25451392 DOI: 10.1016/J.Jad.2014.09.035 |
0.405 |
|
| 2014 |
Young AH. The effects of HPA axis function on cognition and its implications for the pathophysiology of bipolar disorder. Harvard Review of Psychiatry. 22: 331-3. PMID 25377604 DOI: 10.1097/HRP.0000000000000020 |
0.366 |
|
| 2014 |
Taylor DM, Cornelius V, Smith L, Young AH. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatrica Scandinavica. 130: 452-69. PMID 25283309 DOI: 10.1111/acps.12343 |
0.392 |
|
| 2014 |
Wise T, Cleare AJ, Herane A, Young AH, Arnone D. Diagnostic and therapeutic utility of neuroimaging in depression: an overview. Neuropsychiatric Disease and Treatment. 10: 1509-22. PMID 25187715 DOI: 10.2147/NDT.S50156 |
0.379 |
|
| 2014 |
Garay RP, Llorca PM, Young AH, Hameg A, Samalin L. Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment. Drug Discovery Today. 19: 1792-800. PMID 25066425 DOI: 10.1016/j.drudis.2014.07.010 |
0.442 |
|
| 2014 |
Grant N, Hotopf M, Breen G, Cleare A, Grey N, Hepgul N, King S, Moran P, Pariante CM, Wingrove J, Young AH, Tylee A. Predicting outcome following psychological therapy in IAPT (PROMPT): a naturalistic project protocol. Bmc Psychiatry. 14: 170. PMID 24910361 DOI: 10.1186/1471-244X-14-170 |
0.403 |
|
| 2014 |
Asherson P, Young AH, Eich-Höchli D, Moran P, Porsdal V, Deberdt W. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Current Medical Research and Opinion. 30: 1657-72. PMID 24804976 DOI: 10.1185/03007995.2014.915800 |
0.364 |
|
| 2014 |
Keedwell PA, Young AH. Emerging drugs for bipolar depression: an update. Expert Opinion On Emerging Drugs. 19: 25-36. PMID 24397318 DOI: 10.1517/14728214.2014.872628 |
0.4 |
|
| 2014 |
Lloyd AJ, Ali HE, Nesbitt D, Moore PB, Young AH, Ferrier IN. Corpus callosum changes in euthymic bipolar affective disorder. The British Journal of Psychiatry : the Journal of Mental Science. 204: 129-36. PMID 24357572 DOI: 10.1192/bjp.bp.112.123687 |
0.354 |
|
| 2014 |
Turner P, Kantaria R, Young AH. A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: a European perspective. Journal of Psychopharmacology (Oxford, England). 28: 85-98. PMID 24108407 DOI: 10.1177/0269881113507640 |
0.387 |
|
| 2014 |
Gallagher P, Gray JM, Watson S, Young AH, Ferrier IN. Neurocognitive functioning in bipolar depression: a component structure analysis. Psychological Medicine. 44: 961-74. PMID 23800475 DOI: 10.1017/S0033291713001487 |
0.432 |
|
| 2014 |
Young AH, McElroy SL, Olausson B, Paulsson B. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 96-112. PMID 22404704 DOI: 10.3109/15622975.2012.665177 |
0.405 |
|
| 2013 |
Young AH, Calabrese JR, Gustafsson U, Berk M, McElroy SL, Thase ME, Suppes T, Earley W. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders. 1: 10. PMID 25505677 DOI: 10.1186/2194-7511-1-10 |
0.386 |
|
| 2013 |
Gervain J, Vines BW, Chen LM, Seo RJ, Hensch TK, Werker JF, Young AH. Valproate reopens critical-period learning of absolute pitch. Frontiers in Systems Neuroscience. 7: 102. PMID 24348349 DOI: 10.3389/Fnsys.2013.00102 |
0.728 |
|
| 2013 |
Watson S, Gallagher P, Dougall D, Porter R, Moncrieff J, Ferrier IN, Young AH. Childhood trauma in bipolar disorder. The Australian and New Zealand Journal of Psychiatry. 48: 564-570. PMID 24343193 DOI: 10.1177/0004867413516681 |
0.416 |
|
| 2013 |
Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. The Cochrane Database of Systematic Reviews. 10: CD003196. PMID 24132760 DOI: 10.1002/14651858.CD003196.pub2 |
0.423 |
|
| 2013 |
Young AH. Review: lithium reduces the risk of suicide compared with placebo in people with depression and bipolar disorder. Evidence-Based Mental Health. 16: 112. PMID 24046391 DOI: 10.1136/eb-2013-101493 |
0.432 |
|
| 2013 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, ... ... Young AH, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185 |
0.434 |
|
| 2013 |
Colasanti A, Owen DR, Grozeva D, Rabiner EA, Matthews PM, Craddock N, Young AH. Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO). Psychoneuroendocrinology. 38: 2826-9. PMID 23942012 DOI: 10.1016/j.psyneuen.2013.07.007 |
0.361 |
|
| 2013 |
Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Young AH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/Ng.2711 |
0.419 |
|
| 2013 |
Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH, Joyce E, Rowe J, Wellsted D, Nutt DJ, Sahakian BJ. The size, burden and cost of disorders of the brain in the UK. Journal of Psychopharmacology (Oxford, England). 27: 761-70. PMID 23884863 DOI: 10.1177/0269881113495118 |
0.39 |
|
| 2013 |
Robinson LJ, Thompson JM, Gallagher P, Gray JM, Young AH, Ferrier IN. Performance monitoring and executive control of attention in euthymic bipolar disorder: employing the CPT-AX paradigm. Psychiatry Research. 210: 457-64. PMID 23880481 DOI: 10.1016/j.psychres.2013.06.039 |
0.322 |
|
| 2013 |
Eric YW, Halari R, Cheng KM, Leung SK, Young AH. Cognitive performance is impaired in euthymic Chinese patients with Bipolar 1 Disorder. Journal of Affective Disorders. 151: 156-63. PMID 23871126 DOI: 10.1016/j.jad.2013.05.070 |
0.349 |
|
| 2013 |
Young AH, Oldani L. Physical health of patients with bipolar disorder. Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists. 5: 4-6. PMID 23857830 DOI: 10.1111/appy.12081 |
0.461 |
|
| 2013 |
Gamma A, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH. Transcultural validity of the Hypomania Checklist-32 (HCL-32) in patients with major depressive episodes. Bipolar Disorders. 15: 701-12. PMID 23848428 DOI: 10.1111/bdi.12101 |
0.419 |
|
| 2013 |
Smith DJ, Young AH. Practical considerations for the development of a psychoeducation programme: lessons from the Cardiff experience. Acta Psychiatrica Scandinavica. Supplementum. 25-8. PMID 23581790 DOI: 10.1111/acps.12121 |
0.458 |
|
| 2013 |
Young AH, Hale A. Patients with bipolar disorder in a bipolar clinic setting: practical steps. Acta Psychiatrica Scandinavica. Supplementum. 19-24. PMID 23581789 DOI: 10.1111/Acps.12120 |
0.383 |
|
| 2013 |
Young AH, Grunze H. Physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica. Supplementum. 3-10. PMID 23581787 DOI: 10.1111/Acps.12117 |
0.392 |
|
| 2013 |
Young AH. Not always on the level: service provision for bipolar disorders. Acta Psychiatrica Scandinavica. Supplementum. 1-2. PMID 23581786 DOI: 10.1111/Acps.12116 |
0.337 |
|
| 2013 |
Young AH, Altamura AC, González-Pinto AM, Millet B, Wiedemann K. Use of asenapine in clinical practice for the management of bipolar mania. Journal of Psychopharmacology (Oxford, England). 27: 3-13. PMID 23535350 DOI: 10.1177/1359786813482534 |
0.418 |
|
| 2013 |
Macritchie KA, Gallagher P, Lloyd AJ, Bastin ME, Vasudev K, Marshall I, Wardlaw JM, Nicol Ferrier I, Brian Moore P, Young AH. Periventricular white matter integrity and cortisol levels in healthy controls and in euthymic patients with bipolar disorder: an exploratory analysis. Journal of Affective Disorders. 148: 249-55. PMID 23399478 DOI: 10.1016/j.jad.2012.12.002 |
0.378 |
|
| 2013 |
Perugi G, Angst J, Azorin JM, Bowden C, Vieta E, Young AH. The bipolar-borderline personality disorders connection in major depressive patients. Acta Psychiatrica Scandinavica. 128: 376-83. PMID 23379930 DOI: 10.1111/acps.12083 |
0.471 |
|
| 2013 |
Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH. Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. European Archives of Psychiatry and Clinical Neuroscience. 263: 663-73. PMID 23370488 DOI: 10.1007/s00406-013-0393-4 |
0.463 |
|
| 2013 |
Perugi G, Angst J, Azorin JM, Bowden C, Vieta E, Young AH. Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study. Journal of Affective Disorders. 144: 72-8. PMID 22858216 DOI: 10.1016/j.jad.2012.06.008 |
0.469 |
|
| 2013 |
Young AH, Eberhard J, Weiller E. Efficacy of asenapine in manic episodes with depressive symptoms: a review of post-hoc analyses International Journal of Psychiatry in Clinical Practice. 17: 36-37. DOI: 10.3109/13651501.2013.851555 |
0.386 |
|
| 2012 |
Vasudev A, Macritchie K, Rao SK, Geddes J, Young AH. Tiagabine for acute affective episodes in bipolar disorder. The Cochrane Database of Systematic Reviews. 12: CD004694. PMID 23235614 DOI: 10.1002/14651858.CD004694.pub3 |
0.444 |
|
| 2012 |
Bschor T, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH, Krüger S. Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. Journal of Affective Disorders. 142: 45-52. PMID 22954812 DOI: 10.1016/j.jad.2012.03.042 |
0.402 |
|
| 2012 |
Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, Young AH, Ferrier IN. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biological Psychiatry. 72: 943-9. PMID 22770649 DOI: 10.1016/j.biopsych.2012.05.029 |
0.418 |
|
| 2012 |
Young AH. Antidepressants for major depressive episodes: a modest proposal. The Australian and New Zealand Journal of Psychiatry. 46: 293-4. PMID 22508586 DOI: 10.1177/0004867412440894 |
0.374 |
|
| 2012 |
Azorin JM, Angst J, Gamma A, Bowden CL, Perugi G, Vieta E, Young A. Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. Journal of Affective Disorders. 136: 710-715. PMID 22044629 DOI: 10.1016/J.Jad.2011.10.003 |
0.449 |
|
| 2012 |
Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH. Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. European Archives of Psychiatry and Clinical Neuroscience. 262: 3-11. PMID 21818629 DOI: 10.1007/S00406-011-0228-0 |
0.403 |
|
| 2011 |
Vasudev A, Macritchie K, Rao SN, Geddes J, Young AH. Tiagabine in the maintenance treatment of bipolar disorder. The Cochrane Database of Systematic Reviews. CD005173. PMID 22161389 DOI: 10.1002/14651858.CD005173.pub3 |
0.45 |
|
| 2011 |
Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Oxcarbazepine for acute affective episodes in bipolar disorder. The Cochrane Database of Systematic Reviews. CD004857. PMID 22161387 DOI: 10.1002/14651858.CD004857.pub2 |
0.413 |
|
| 2011 |
Hamshere ML, O'Donovan MC, Jones IR, Jones L, Kirov G, Green EK, Moskvina V, Grozeva D, Bass N, McQuillin A, Gurling H, St Clair D, Young AH, Ferrier IN, Farmer A, et al. Polygenic dissection of the bipolar phenotype. The British Journal of Psychiatry : the Journal of Mental Science. 198: 284-8. PMID 21972277 DOI: 10.1192/Bjp.Bp.110.087866 |
0.404 |
|
| 2011 |
Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Archives of General Psychiatry. 68: 791-8. PMID 21810644 DOI: 10.1001/archgenpsychiatry.2011.87 |
0.492 |
|
| 2011 |
Young AH, Rigney U, Shaw S, Emmas C, Thompson JM. Annual cost of managing bipolar disorder to the UK healthcare system. Journal of Affective Disorders. 133: 450-6. PMID 21737141 DOI: 10.1016/j.jad.2011.06.016 |
0.337 |
|
| 2011 |
Young AH, Macpherson H. Detection of bipolar disorder. The British Journal of Psychiatry : the Journal of Mental Science. 199: 3-4. PMID 21719873 DOI: 10.1192/bjp.bp.110.089128 |
0.45 |
|
| 2011 |
Kennedy SH, Young AH, Blier P. Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. Journal of Affective Disorders. 132: S21-8. PMID 21571374 DOI: 10.1016/J.Jad.2011.03.048 |
0.322 |
|
| 2011 |
Young AH. More good news about the magic ion: lithium may prevent dementia. The British Journal of Psychiatry : the Journal of Mental Science. 198: 336-7. PMID 21525515 DOI: 10.1192/bjp.bp.110.082875 |
0.376 |
|
| 2011 |
Iverson GL, Brooks BL, Langenecker SA, Young AH. Identifying a cognitive impairment subgroup in adults with mood disorders. Journal of Affective Disorders. 132: 360-7. PMID 21439647 DOI: 10.1016/J.Jad.2011.03.001 |
0.334 |
|
| 2011 |
Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, Ferreira MA, Ferrier IN, Fraser C, Gordon-Smith K, Green EK, Grozeva D, Gurling HM, Hamshere ML, Heutink P, Holmans PA, ... ... Young AH, et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Molecular Psychiatry. 16: 2-4. PMID 20351715 DOI: 10.1038/Mp.2009.107 |
0.439 |
|
| 2011 |
Colasanti A, Young AH. Major depressive episodes in clinical practice: The state of art and new developments in drug therapy Hot Topics in Neurology and Psychiatry. 13-21. DOI: 10.4147/Htn-111213 |
0.329 |
|
| 2011 |
Krishnan V, Colasanti A, Young AH. Major depressive disorders Hot Topics in Neurology and Psychiatry. DOI: 10.4147/Htn-111200 |
0.459 |
|
| 2011 |
Maron E, Young AH. Bipolar I disorder: current and future management options Future Prescriber. 12: 14-17. DOI: 10.1002/Fps.82 |
0.43 |
|
| 2010 |
Green EK, Grozeva D, Moskvina V, Hamshere ML, Jones IR, Jones L, Forty L, Caesar S, Gordon-Smith K, Fraser C, Russell E, St Clair D, Young AH, Ferrier N, Farmer A, et al. Variation at the GABAA receptor gene, Rho 1 (GABRR1) associated with susceptibility to bipolar schizoaffective disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 1347-9. PMID 20583128 DOI: 10.1002/Ajmg.B.31108 |
0.344 |
|
| 2010 |
Mackay CE, Roddick E, Barrick TR, Lloyd AJ, Roberts N, Crow TJ, Young AH, Ferrier IN. Sex dependence of brain size and shape in bipolar disorder: an exploratory study. Bipolar Disorders. 12: 306-11. PMID 20565437 DOI: 10.1111/j.1399-5618.2010.00804.x |
0.324 |
|
| 2010 |
Severus WE, Lipkovich IA, Licht RW, Young AH, Greil W, Ketter T, Deberdt W, Tohen M. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005. European Psychiatry : the Journal of the Association of European Psychiatrists. 25: 443-9. PMID 20430594 DOI: 10.1016/J.Eurpsy.2009.10.009 |
0.381 |
|
| 2010 |
Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, Green EK, St Clair DM, Young AH, Ferrier N, Farmer AE, McGuffin P, Holmans PA, Owen MJ, O'Donovan MC, Craddock N, et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Archives of General Psychiatry. 67: 318-27. PMID 20368508 DOI: 10.1001/Archgenpsychiatry.2010.25 |
0.368 |
|
| 2010 |
Procyshyn RM, Honer WG, Wu TK, Ko RW, McIsaac SA, Young AH, Johnson JL, Barr AM. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. The Journal of Clinical Psychiatry. 71: 566-73. PMID 20361903 DOI: 10.4088/Jcp.08M04912Gre |
0.368 |
|
| 2010 |
Azorin JM, Bowden CL, Garay RP, Perugi G, Vieta E, Young AH. Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism. Neuropsychiatric Disease and Treatment. 6: 37-46. PMID 20361060 DOI: 10.2147/Ndt.S6741 |
0.329 |
|
| 2010 |
Cousins DA, Moore PB, Watson S, Harrison L, Ferrier IN, Young AH, Lloyd AJ. Pituitary volume and third ventricle width in euthymic patients with bipolar disorder. Psychoneuroendocrinology. 35: 1074-81. PMID 20171783 DOI: 10.1016/j.psyneuen.2010.01.008 |
0.367 |
|
| 2010 |
Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). The Journal of Clinical Psychiatry. 71: 150-62. PMID 20122369 DOI: 10.4088/JCP.08m04995gre |
0.393 |
|
| 2010 |
McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). The Journal of Clinical Psychiatry. 71: 163-74. PMID 20122366 DOI: 10.4088/JCP.08m04942gre |
0.391 |
|
| 2010 |
Hellemans KG, Verma P, Yoon E, Yu WK, Young AH, Weinberg J. Prenatal alcohol exposure and chronic mild stress differentially alter depressive- and anxiety-like behaviors in male and female offspring. Alcoholism, Clinical and Experimental Research. 34: 633-45. PMID 20102562 DOI: 10.1111/j.1530-0277.2009.01132.x |
0.349 |
|
| 2010 |
Macritchie KA, Lloyd AJ, Bastin ME, Vasudev K, Gallagher P, Eyre R, Marshall I, Wardlaw JM, Ferrier IN, Moore PB, Young AH. White matter microstructural abnormalities in euthymic bipolar disorder. The British Journal of Psychiatry : the Journal of Mental Science. 196: 52-8. PMID 20044661 DOI: 10.1192/bjp.bp.108.058586 |
0.331 |
|
| 2010 |
Seo RJ, MacPherson H, Young AH. Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder Pharmaceuticals. 3: 3522-3542. DOI: 10.3390/Ph3123522 |
0.414 |
|
| 2010 |
Craddock N, Jones L, Jones IR, Kirov G, Green EK, Grozeva D, Moskvina V, Nikolov I, Hamshere ML, Vukcevic D, Caesar S, Gordon-Smith K, Fraser C, Russell E, Norton N, ... ... Young AH, et al. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype (Molecular Psychiatry (2010) 15 (146-153) DOI: 10.1038/mp.2008.66) Molecular Psychiatry. 15: 1121. DOI: 10.1038/Mp.2010.62 |
0.327 |
|
| 2010 |
Perugi G, Angst J, Azorin JM, Bowden CL, Vieta E, Young A. P.2.e.018 Frequency of mixed states in patients with a major depressive episode:the BRIDGE MIX study European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70591-5 |
0.332 |
|
| 2010 |
Vieta E, Angst J, Azorin J-, Bowden CL, Perugi G, Young AH. PW01-39 - Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire European Psychiatry. 25: 1458. DOI: 10.1016/S0924-9338(10)71441-3 |
0.458 |
|
| 2010 |
Iverson GL, McIntosh D, Kjernisted K, Ferguson KE, Young AH. Efficient identification of cognitive impairment in depression with computerized testing Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.02.056 |
0.32 |
|
| 2010 |
Iverson GL, McIntosh D, Ferguson KE, Kjernisted K, Young AH. A new scale for assessing perceived cognitive impairment in patients with depression Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.02.055 |
0.329 |
|
| 2010 |
Young AH, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E. Characteristics of patients with bipolar disorder presenting a current major depressive episode: Analysis in eight countries Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.01.056 |
0.456 |
|
| 2010 |
Young A. Screening for bipolar disorder: How useful are currently available instruments and what do they tell us about the nosology and epidemiology of mood disorders? Journal of Affective Disorders. 122. DOI: 10.1016/J.Jad.2010.01.053 |
0.391 |
|
| 2010 |
Young AH, Nemeroff CB. Pharmacological Treatment of Bipolar Depression Bipolar Disorder: Clinical and Neurobiological Foundations. 294-303. DOI: 10.1002/9780470661277.ch23 |
0.417 |
|
| 2009 |
Iverson GL, Brooks BL, Young AH. Identifying neurocognitive impairment in depression using computerized testing. Applied Neuropsychology. 16: 254-61. PMID 20183180 DOI: 10.1080/09084280903297594 |
0.382 |
|
| 2009 |
Iverson GL, Brooks BL, Young AH. Rapid computerized assessment of neurocognitive deficits in bipolar disorder. Applied Neuropsychology. 16: 207-13. PMID 20183173 DOI: 10.1080/09084280903098778 |
0.389 |
|
| 2009 |
Cousins DA, Butts K, Young AH. The role of dopamine in bipolar disorder. Bipolar Disorders. 11: 787-806. PMID 19922550 DOI: 10.1111/j.1399-5618.2009.00760.x |
0.408 |
|
| 2009 |
Young AH. Bipolar disorder: diagnostic conundrums and associated comorbidities. The Journal of Clinical Psychiatry. 70: e26. PMID 19758515 DOI: 10.4088/JCP.7067br6c |
0.447 |
|
| 2009 |
Minton GO, Young AH, McQuade R, Fairchild G, Ingram CD, Gartside SE. Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2265-74. PMID 19494803 DOI: 10.1038/npp.2009.53 |
0.336 |
|
| 2009 |
Lloyd AJ, Moore PB, Cousins DA, Thompson JM, McAllister VL, Hughes JH, Ferrier IN, Young AH. White matter lesions in euthymic patients with bipolar disorder. Acta Psychiatrica Scandinavica. 120: 481-91. PMID 19489745 DOI: 10.1111/j.1600-0447.2009.01416.x |
0.35 |
|
| 2009 |
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders. 11: 225-55. PMID 19419382 DOI: 10.1111/J.1399-5618.2009.00672.X |
0.459 |
|
| 2009 |
Goswami U, Sharma A, Varma A, Gulrajani C, Ferrier IN, Young AH, Gallagher P, Thompson JM, Moore PB. The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatrica Scandinavica. 120: 456-63. PMID 19416126 DOI: 10.1111/j.1600-0447.2009.01390.x |
0.33 |
|
| 2009 |
Young A, Seim D. Review: long term use of antidepressants for bipolar disorder reduces depressive episodes but increases risk of mania. Evidence-Based Mental Health. 12: 49-49. PMID 19395608 DOI: 10.1136/Ebmh.12.2.49 |
0.43 |
|
| 2009 |
McIsaac SA, Young AH. The role of hypothalamic pituitary-adrenal axis dysfunction in the etiology of depressive disorders. Drugs of Today (Barcelona, Spain : 1998). 45: 127-33. PMID 19343232 DOI: 10.1358/dot.2009.45.2.1336104 |
0.32 |
|
| 2009 |
Douglas KM, Porter RJ, Frampton CM, Gallagher P, Young AH. Abnormal response to failure in unmedicated major depression. Journal of Affective Disorders. 119: 92-9. PMID 19285346 DOI: 10.1016/j.jad.2009.02.018 |
0.362 |
|
| 2009 |
Thompson JM, Gray JM, Crawford JR, Hughes JH, Young AH, Ferrier IN. Differential deficit in executive control in euthymic bipolar disorder. Journal of Abnormal Psychology. 118: 146-60. PMID 19222321 DOI: 10.1037/a0014740 |
0.335 |
|
| 2009 |
Young AH, Oren DA, Lowy A, McQuade RD, Marcus RN, Carson WH, Spiller NH, Torbeyns AF, Sanchez R. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. The British Journal of Psychiatry : the Journal of Mental Science. 194: 40-8. PMID 19118324 DOI: 10.1192/bjp.bp.108.049965 |
0.308 |
|
| 2009 |
Thomas AJ, Gallagher P, Robinson LJ, Porter RJ, Young AH, Ferrier IN, O'Brien JT. A comparison of neurocognitive impairment in younger and older adults with major depression. Psychological Medicine. 39: 725-33. PMID 18667097 DOI: 10.1017/S0033291708004042 |
0.371 |
|
| 2009 |
McIsaac SA, Westrin Å, Young AH. Antiglucocorticoids in psychiatry Advances in Psychiatric Treatment. 15: 242-249. DOI: 10.1192/Apt.Bp.105.001834 |
0.353 |
|
| 2009 |
Young A. C.10.03 What is new in treating patients with major depressive disorder who show inadequate response to antidepressants European Neuropsychopharmacology. 19: S713. DOI: 10.1016/S0924-977X(09)71162-9 |
0.323 |
|
| 2009 |
Young AH, Azorin JM, Perugi G, Vieta E, Bowden C, Cornelius V, Smith LA. P.2.e.026 Valproate for acute bipolar depression: systematic review and meta-analysis European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70725-4 |
0.362 |
|
| 2009 |
Young AH, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E. P.2.e.01l Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countries European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70710-2 |
0.42 |
|
| 2009 |
Paulsson B, Olausson B, Young AH. P01-210 Quetiapine: Mood stabilization across all phases of bipolar disorder European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70831-4 |
0.44 |
|
| 2008 |
Mokhber N, Lane CJ, Azarpazhooh MR, Salari E, Fayazi R, Shakeri MT, Young AH. Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran. Neuropsychiatric Disease and Treatment. 4: 227-34. PMID 18728802 DOI: 10.2147/Ndt.S2316 |
0.403 |
|
| 2008 |
Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, ... ... Young AH, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics. 40: 1056-8. PMID 18711365 DOI: 10.1038/Ng.209 |
0.334 |
|
| 2008 |
Franks M, Macritchie KA, Mahmood T, Young AH. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study. Journal of Psychopharmacology (Oxford, England). 22: 452-6. PMID 18635725 DOI: 10.1177/0269881107085238 |
0.35 |
|
| 2008 |
Dankert ME, Brensinger CM, Metzger KL, Li C, Koleva SG, Mesén A, Laprade B, Wiguna T, Han C, Farooq S, Severus WE, Gayares JG, Langosch JM, Lallart X, Tateno M, ... ... Young A, et al. Attitudes of patients and family members towards implantable psychiatric medication. Schizophrenia Research. 105: 279-86. PMID 18571376 DOI: 10.1016/J.Schres.2008.05.008 |
0.308 |
|
| 2008 |
Michalak EE, Murray G, Young AH, Lam RW. Burden of bipolar depression: impact of disorder and medications on quality of life. Cns Drugs. 22: 389-406. PMID 18399708 DOI: 10.2165/00023210-200822050-00003 |
0.493 |
|
| 2008 |
Gallagher P, Watson S, Elizabeth Dye C, Young AH, Nicol Ferrier I. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia. Journal of Psychiatric Research. 42: 1037-41. PMID 18255098 DOI: 10.1016/j.jpsychires.2007.12.005 |
0.355 |
|
| 2008 |
Vasudev A, Macritchie K, Watson S, Geddes JR, Young AH. Oxcarbazepine in the maintenance treatment of bipolar disorder. The Cochrane Database of Systematic Reviews. CD005171. PMID 18254071 DOI: 10.1002/14651858.CD005171.pub2 |
0.422 |
|
| 2008 |
Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P. Antiglucocorticoid treatments for mood disorders. The Cochrane Database of Systematic Reviews. CD005168. PMID 18254070 DOI: 10.1002/14651858.CD005168.pub2 |
0.357 |
|
| 2008 |
Young A, McElroy S, Chang W, Olaulsson B, Paulsson B, Brecher M. P.2.e.023 Placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN II) European Neuropsychopharmacology. 18. DOI: 10.1016/S0924-977X(08)70530-3 |
0.344 |
|
| 2008 |
Young AH, Carlsson A, Olausson B, Paulsson B, Brecher M. A double-blind, placebo-controlled study with acute and continuation phase of Quetiapine and Lithium in adults with bipolar depression (Embolden I) European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.450 |
0.368 |
|
| 2007 |
Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use? The British Journal of Psychiatry : the Journal of Mental Science. 191: 474-6. PMID 18055949 DOI: 10.1192/bjp.bp.107.043133 |
0.414 |
|
| 2007 |
Kingdon D, Young AH. Research into putative biological mechanisms of mental disorders has been of no value to clinical psychiatry. The British Journal of Psychiatry : the Journal of Mental Science. 191: 285-90. PMID 17906237 DOI: 10.1192/bjp.bp.107.035675 |
0.362 |
|
| 2007 |
Thompson JM, Gray JM, Hughes JH, Watson S, Young AH, Ferrier IN. Impaired working memory monitoring in euthymic bipolar patients. Bipolar Disorders. 9: 478-89. PMID 17680918 DOI: 10.1111/j.1399-5618.2007.00470.x |
0.332 |
|
| 2007 |
Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disorders. 9: 394-412. PMID 17547586 DOI: 10.1111/j.1399-5618.2007.00490.x |
0.326 |
|
| 2007 |
Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. International Clinical Psychopharmacology. 22: 212-20. PMID 17519644 DOI: 10.1097/YIC.0b013e328080ca57 |
0.319 |
|
| 2007 |
Mackin P, Gallagher P, Watson S, Young AH, Ferrier IN. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. The Australian and New Zealand Journal of Psychiatry. 41: 321-6. PMID 17464718 DOI: 10.1080/00048670701213211 |
0.344 |
|
| 2007 |
Gallagher P, Robinson LJ, Gray JM, Porter RJ, Young AH. Neurocognitive function following remission in major depressive disorder: potential objective marker of response? The Australian and New Zealand Journal of Psychiatry. 41: 54-61. PMID 17464681 DOI: 10.1080/00048670601057734 |
0.455 |
|
| 2007 |
Watson S, Gallagher P, Smith MS, Young AH, Ferrier IN. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients. Psychoneuroendocrinology. 32: 464-9. PMID 17442500 DOI: 10.1016/j.psyneuen.2007.02.010 |
0.429 |
|
| 2007 |
Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophrenia Research. 90: 258-65. PMID 17222537 DOI: 10.1016/j.schres.2006.11.020 |
0.369 |
|
| 2007 |
Cousins DA, Young AH. The armamentarium of treatments for bipolar disorder: a review of the literature. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 411-31. PMID 17176493 DOI: 10.1017/S1461145706007413 |
0.474 |
|
| 2007 |
Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. The dex/CRH test and the DST in patients with bipolar disorder and major depressive disorder Psychoneuroendocrinology. 32: 92-94. DOI: 10.1016/J.Psyneuen.2006.10.007 |
0.465 |
|
| 2006 |
Gray J, Venn H, Montagne B, Murray L, Burt M, Frigerio E, Perrett D, Young AH. Bipolar patients show mood-congruent biases in sensitivity to facial expressions of emotion when exhibiting depressed symptoms, but not when exhibiting manic symptoms. Cognitive Neuropsychiatry. 11: 505-20. PMID 17354085 DOI: 10.1080/13546800544000028 |
0.355 |
|
| 2006 |
Young AH, Geddes JR, Macritchie K, Rao SN, Watson S, Vasudev A. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability. The Cochrane Database of Systematic Reviews. CD004694. PMID 16856056 DOI: 10.1002/14651858.CD004694.pub2 |
0.438 |
|
| 2006 |
Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. The dex/CRH test--is it better than the DST? Psychoneuroendocrinology. 31: 889-94. PMID 16701957 DOI: 10.1016/j.psyneuen.2006.03.001 |
0.339 |
|
| 2006 |
Young AH. Antiglucocoticoid treatments for depression. The Australian and New Zealand Journal of Psychiatry. 40: 402-5. PMID 16683965 DOI: 10.1111/j.1440-1614.2006.01813.x |
0.425 |
|
| 2006 |
Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. Journal of Affective Disorders. 93: 105-15. PMID 16677713 DOI: 10.1016/j.jad.2006.02.016 |
0.325 |
|
| 2006 |
Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, Thompson JM, Moore PB. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. The British Journal of Psychiatry : the Journal of Mental Science. 188: 366-73. PMID 16582064 DOI: 10.1192/bjp.188.4.366 |
0.402 |
|
| 2006 |
Young AH, Newham JI. Lithium in maintenance therapy for bipolar disorder. Journal of Psychopharmacology (Oxford, England). 20: 17-22. PMID 16551668 DOI: 10.1177/1359786806063072 |
0.467 |
|
| 2006 |
Vasudev K, Macritchie K, Geddes J, Watson S, Young A. Topiramate for acute affective episodes in bipolar disorder. The Cochrane Database of Systematic Reviews. CD003384. PMID 16437453 DOI: 10.1002/14651858.CD003384.pub2 |
0.425 |
|
| 2006 |
Watson S, Thompson JM, Ritchie JC, Nicol Ferrier I, Young AH. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. Bipolar Disorders. 8: 85-90. PMID 16411985 DOI: 10.1111/j.1399-5618.2006.00280.x |
0.385 |
|
| 2006 |
Green EK, Raybould R, Macgregor S, Hyde S, Young AH, O'Donovan MC, Owen MJ, Kirov G, Jones L, Jones I, Craddock N. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. The British Journal of Psychiatry : the Journal of Mental Science. 188: 21-5. PMID 16388065 DOI: 10.1192/Bjp.Bp.105.009969 |
0.333 |
|
| 2006 |
Venn HR, Watson S, Gallagher P, Young AH. Facial expression perception: an objective outcome measure for treatment studies in mood disorders? The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 229-45. PMID 16316484 DOI: 10.1017/S1461145705006012 |
0.341 |
|
| 2006 |
Watson S, Gallagher P, Ferrier IN, Young AH. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. Journal of Psychiatric Research. 40: 353-9. PMID 16165159 DOI: 10.1016/j.jpsychires.2005.08.001 |
0.433 |
|
| 2006 |
Young A. Progress in the treatment of bipolar disorder Neuropsychiatric Disease and Treatment. 2: 119-120. DOI: 10.2147/Nedt.2006.2.2.119 |
0.469 |
|
| 2006 |
Young AH, Ferrier IN. Overview of treatment for mood disorders Psychiatry Mmc. 5: 183-184. DOI: 10.1053/J.Mppsy.2006.03.001 |
0.421 |
|
| 2005 |
Mackin P, Young AH. QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study. The Journal of Clinical Psychiatry. 66: 1386-91. PMID 16420075 DOI: 10.4088/Jcp.V66N1107 |
0.309 |
|
| 2005 |
Mackin P, Young AH. Prognosis in obesity: obesity in severe mental illness poses particular problems. Bmj (Clinical Research Ed.). 331: 452-3; author reply . PMID 16110077 DOI: 10.1136/bmj.331.7514.452-b |
0.315 |
|
| 2005 |
Young AH. Metyrapone is an effective adjuvant treatment for major depression. Evidence-Based Mental Health. 8: 72. PMID 16043614 DOI: 10.1136/Ebmh.8.3.72 |
0.38 |
|
| 2005 |
Goodwin G, Young AH. Using guidelines in real clinical situations: clozapine and breast feeding in bipolar disorder. Journal of Psychopharmacology (Oxford, England). 19: 317-8. PMID 15888520 DOI: 10.1177/0269881105054667 |
0.332 |
|
| 2005 |
Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. Journal of Psychopharmacology (Oxford, England). 19: 293-300. PMID 15888515 DOI: 10.1177/0269881105051541 |
0.474 |
|
| 2005 |
Daban C, Vieta E, Mackin P, Young AH. Hypothalamic-pituitary-adrenal axis and bipolar disorder. The Psychiatric Clinics of North America. 28: 469-80. PMID 15826743 DOI: 10.1016/j.psc.2005.01.005 |
0.453 |
|
| 2005 |
Watson S, Thompson JM, Malik N, Ferrier IN, Young AH. Temporal stability of the dex/CRH test in patients with rapid-cycling bipolar I disorder: a pilot study. The Australian and New Zealand Journal of Psychiatry. 39: 244-8. PMID 15777360 DOI: 10.1111/j.1440-1614.2005.01560.x |
0.363 |
|
| 2005 |
Gallagher P, Watson S, Smith MS, Ferrier IN, Young AH. Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia. Biological Psychiatry. 57: 155-61. PMID 15652874 DOI: 10.1016/j.biopsych.2004.10.017 |
0.338 |
|
| 2005 |
Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, Young AH. Neurocognitive impairment in euthymic patients with bipolar affective disorder. The British Journal of Psychiatry : the Journal of Mental Science. 186: 32-40. PMID 15630121 DOI: 10.1192/bjp.186.1.32 |
0.414 |
|
| 2005 |
Young A. Book Review: Post-Traumatic Stress Disorder: Malady or Myth?: Transcultural Psychiatry. 42: 155-157. DOI: 10.1177/136346150504200112 |
0.331 |
|
| 2004 |
Young AH. Cortisol in mood disorders. Stress (Amsterdam, Netherlands). 7: 205-8. PMID 16019585 DOI: 10.1080/10253890500069189 |
0.443 |
|
| 2004 |
McQuade R, Leitch MM, Gartside SE, Young AH. Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain. Journal of Psychopharmacology (Oxford, England). 18: 496-501. PMID 15582915 DOI: 10.1177/0269881104047276 |
0.319 |
|
| 2004 |
Monks PJ, Thompson JM, Bullmore ET, Suckling J, Brammer MJ, Williams SC, Simmons A, Giles N, Lloyd AJ, Harrison CL, Seal M, Murray RM, Ferrier IN, Young AH, Curtis VA. A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disorders. 6: 550-64. PMID 15541071 DOI: 10.1111/J.1399-5618.2004.00147.X |
0.306 |
|
| 2004 |
Mackin P, Young AH. Rapid cycling bipolar disorder: historical overview and focus on emerging treatments. Bipolar Disorders. 6: 523-9. PMID 15541068 DOI: 10.1111/j.1399-5618.2004.00156.x |
0.386 |
|
| 2004 |
Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report. Bipolar Disorders. 6: 319-22. PMID 15225150 DOI: 10.1111/j.1399-5618.2004.00122.x |
0.326 |
|
| 2004 |
Venn HR, Gray JM, Montagne B, Murray LK, Michael Burt D, Frigerio E, Perrett DI, Young AH. Perception of facial expressions of emotion in bipolar disorder. Bipolar Disorders. 6: 286-93. PMID 15225145 DOI: 10.1111/J.1399-5618.2004.00121.X |
0.343 |
|
| 2004 |
Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. The British Journal of Psychiatry : the Journal of Mental Science. 184: 496-502. PMID 15172943 DOI: 10.1192/bjp.184.6.496 |
0.401 |
|
| 2004 |
Lloyd AJ, Ferrier IN, Barber R, Gholkar A, Young AH, O'Brien JT. Hippocampal volume change in depression: late- and early-onset illness compared. The British Journal of Psychiatry : the Journal of Mental Science. 184: 488-95. PMID 15172942 DOI: 10.1192/Bjp.184.6.488 |
0.372 |
|
| 2004 |
Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1538-45. PMID 15127079 DOI: 10.1038/sj.npp.1300471 |
0.453 |
|
| 2004 |
Calabrese JR, Kasper S, Johnson G, Tajima O, Vieta E, Yatham LN, Young AH. International Consensus Group on Bipolar I Depression Treatment Guidelines. The Journal of Clinical Psychiatry. 65: 571-9. PMID 15119923 DOI: 10.4088/Jcp.V65N0419 |
0.398 |
|
| 2004 |
Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology. 173: 1-17. PMID 15007595 DOI: 10.1007/s00213-004-1774-1 |
0.354 |
|
| 2004 |
Rendell JM, Juszczak E, Hainsworth J, Gucht EV, Healey C, Morriss R, Ferrier N, Young AH, Young H, Goodwin GM, Geddes JR. Developing the BALANCE trail--the role of the pilot study and start-up phase. Bipolar Disorders. 6: 26-31. PMID 14996138 DOI: 10.1046/J.1399-5618.2003.00088.X |
0.318 |
|
| 2004 |
Macmillan I, Young A, Ferrier N. Mood (affective) disorders Medicine. 32: 14-16. DOI: 10.1383/Medc.32.7.14.36678 |
0.489 |
|
| 2004 |
Young A. Descriptions and Prescriptions: Values, Mental Disorders, and the DSMs Journal of Nervous and Mental Disease. 192: 167. DOI: 10.1097/01.Nmd.0000110288.54788.D3 |
0.346 |
|
| 2003 |
Young A. Evolutionary narratives about mental disorders. Anthropology & Medicine. 10: 239-53. PMID 26954839 DOI: 10.1080/1364847032000122890 |
0.354 |
|
| 2003 |
Lloyd AJ, Harrison CL, Ferrier IN, Young AH. The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better. Journal of Psychopharmacology (Oxford, England). 17: 230-3. PMID 12870572 DOI: 10.1177/0269881103017002013 |
0.382 |
|
| 2003 |
Watson S, Young AH. Cinders, you shall go to the ball. The British Journal of Psychiatry : the Journal of Mental Science. 183: 79-80. PMID 12835256 DOI: 10.1192/Bjp.183.1.79-A |
0.37 |
|
| 2003 |
Porter RJ, Gallagher P, Watson S, Smith MS, Young AH. Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients. Psychopharmacology. 169: 77-83. PMID 12728300 DOI: 10.1007/s00213-003-1475-1 |
0.434 |
|
| 2003 |
Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 182: 214-20. PMID 12611784 DOI: 10.1192/Bjp.182.3.214 |
0.423 |
|
| 2003 |
Moorhead SR, Young AH. Evidence for a late onset bipolar-I disorder sub-group from 50 years. Journal of Affective Disorders. 73: 271-7. PMID 12547296 DOI: 10.1016/S0165-0327(01)00476-1 |
0.346 |
|
| 2003 |
Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE. Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 119-25. PMID 12496947 DOI: 10.1038/sj.npp.1300016 |
0.314 |
|
| 2003 |
Vieta E, Young A, Berk M, Asnis G, Calabrese J, Sachs G, Bowden C. P.1.213 Safety and tolerability of lamotrigine in bipolar I disorder European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91923-7 |
0.358 |
|
| 2003 |
Calabrese J, Young AH, Bowden C, Antonijevic Z, Evoniuk G. P.1.212 Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91922-5 |
0.338 |
|
| 2002 |
Turkington D, Grant JB, Ferrier IN, Rao NS, Linsley KR, Young AH. A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. The Journal of Clinical Psychiatry. 63: 778-81. PMID 12363117 DOI: 10.4088/Jcp.V63N0905 |
0.312 |
|
| 2002 |
Young AH, Hughes JH, Marsh VR, Ashton CH. Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: a preliminary study. Journal of Affective Disorders. 69: 83-92. PMID 12103455 DOI: 10.1016/S0165-0327(00)00382-7 |
0.381 |
|
| 2002 |
Young AH, Gallagher P, Porter RJ. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. The American Journal of Psychiatry. 159: 1237-9. PMID 12091208 DOI: 10.1176/Appi.Ajp.159.7.1237 |
0.39 |
|
| 2002 |
Barnard L, Young AH, Pearson J, Geddes J, O'Brien G. A systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology (Oxford, England). 16: 93-101. PMID 11949778 DOI: 10.1177/026988110201600113 |
0.367 |
|
| 2002 |
Hughes JH, Gallagher P, Young AH. Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 123-8. PMID 11872328 DOI: 10.1016/S0924-977X(01)00145-6 |
0.325 |
|
| 2002 |
Gallagher P, Young A. Cortisol/DHEA Ratios in Depression Neuropsychopharmacology. 26: 410-410. PMID 11850157 DOI: 10.1016/S0893-133X(01)00362-1 |
0.359 |
|
| 2002 |
Harrison L, Vanoli A, Steen N, Young A. Economics of high dose venlafaxine in depressed patients European Neuropsychopharmacology. 12: 207-208. DOI: 10.1016/S0924-977X(02)80216-4 |
0.335 |
|
| 2002 |
Young A. The self-traumatized perpetrator as a “transient mental illness” Evolution Psychiatrique. 67: 630-650. DOI: 10.1016/S0014-3855(02)00162-7 |
0.329 |
|
| 2002 |
Eriksson E, Endicott J, Andersch B, Angst J, Demyttenaere K, Facchinetti F, Lanczik M, Montgomery S, Muscettola G, O'Brien PMS, Studd J, Sundblad C, Young AH. New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder Archives of Womens Mental Health. 4: 111-119. DOI: 10.1007/S007370200009 |
0.433 |
|
| 2001 |
Macritchie KA, Young AH. Emerging targets for the treatment of depressive disorder. Expert Opinion On Therapeutic Targets. 5: 601-612. PMID 12540286 DOI: 10.1517/14728222.5.5.601 |
0.4 |
|
| 2001 |
Young A. Our traumatic neurosis and its brain Science in Context. 14: 661-683. PMID 12180467 DOI: 10.1017/S0269889701000291 |
0.309 |
|
| 2001 |
Stanton BR, David AS, Cleare AJ, Sierra M, Lambert MV, Phillips ML, Porter RJ, Gallagher P, Young AH. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Research. 104: 85-9. PMID 11600192 DOI: 10.1016/S0165-1781(01)00291-8 |
0.449 |
|
| 2001 |
Watson S, Young AH. Antidepressant effects of hydrocortisone. The American Journal of Psychiatry. 158: 1536-7. PMID 11532764 DOI: 10.1176/Appi.Ajp.158.9.1536-A |
0.315 |
|
| 2001 |
Watson S, Young AH. Yohimbine for anxiety disorders. The American Journal of Psychiatry. 158: 1340. PMID 11481195 DOI: 10.1176/Appi.Ajp.158.8.1340 |
0.385 |
|
| 2001 |
Ferrier IN, MacMillan IC, Young AH. The search for the wandering thymostat: a review of some developments in bipolar disorder research. The British Journal of Psychiatry. Supplement. 41: s103-6. PMID 11450169 DOI: 10.1192/Bjp.178.41.S103 |
0.394 |
|
| 2001 |
Watson S, Young AH. Bipolar disorders: new approaches to therapy. Expert Opinion On Pharmacotherapy. 2: 601-12. PMID 11336610 DOI: 10.1517/14656566.2.4.601 |
0.455 |
|
| 2001 |
Golightly KL, Lloyd JA, Hobson JE, Gallagher P, Mercer G, Young AH. Acute tryptophan depletion in schizophrenia. Psychological Medicine. 31: 75-84. PMID 11200962 DOI: 10.1017/S0033291799003062 |
0.352 |
|
| 2001 |
Young A. Bipolar Medications: Mechanisms of Action British Journal of Psychiatry. 179: 185-186. DOI: 10.1192/Bjp.179.2.185-A |
0.411 |
|
| 2001 |
Young AH. Men and women with chronic major depression responded differently to sertraline and imipramine Evidence-Based Mental Health. 4: 114-114. DOI: 10.1136/Ebmh.4.4.114 |
0.309 |
|
| 2001 |
Monks PJ, Thompson J, Lloyd AJ, Harrison CL, Bullmore ET, Brammer M, Williams S, Simmons A, Murray R, Ferrier IN, Young AH, Curtis V. Using fMRI to study euthymic bipolar patients: studies of verbal fluency. Neuroimage. 13: 1074. DOI: 10.1016/S1053-8119(01)92403-6 |
0.338 |
|
| 2000 |
Young AH, Hughes JH, Ashton CH. Brain 5-HT function in bipolar affective disorder. Acta Neuropsychiatrica. 12: 91-95. PMID 26975260 DOI: 10.1017/S0924270800035481 |
0.401 |
|
| 2000 |
Young AH, Macritchie KA, Calabrese JR. Treatment of bipolar affective disorder. Bmj (Clinical Research Ed.). 321: 1302-3. PMID 11090500 DOI: 10.1136/Bmj.321.7272.1302 |
0.495 |
|
| 2000 |
Hughes JH, Dunne F, Young AH. Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium. The British Journal of Psychiatry : the Journal of Mental Science. 177: 447-51. PMID 11059999 DOI: 10.1192/Bjp.177.5.447 |
0.383 |
|
| 2000 |
Young AH, Gallagher P, Porter RJ. 244. Neuropsychological function in drug-free depressives Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00508-4 |
0.338 |
|
| 1999 |
Young AH, Sahakian BJ, Robbins TW, Cowen PJ. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology. 145: 260-6. PMID 10494574 DOI: 10.1007/s002130051057 |
0.376 |
|
| 1999 |
Kirmayer LJ, Young A. Culture and context in the evolutionary concept of mental disorder. Journal of Abnormal Psychology. 108: 446-452. PMID 10466268 DOI: 10.1037//0021-843X.108.3.446 |
0.342 |
|
| 1999 |
Man MS, MacMillan I, Scott J, Young AH. Mood, neuropsychological function and cognitions in premenstrual dysphoric disorder. Psychological Medicine. 29: 727-33. PMID 10405094 DOI: 10.1017/S0033291798007715 |
0.35 |
|
| 1999 |
Macmillan I, Young A. Bipolar II disorder vs. premenstrual dysphoric disorder. The Journal of Clinical Psychiatry. 60: 409-410. PMID 10401923 DOI: 10.4088/Jcp.V60N0611C |
0.388 |
|
| 1999 |
Golightly L, Young A. Sex Hormones and Mental Health Advances in Psychiatric Treatment. 5: 126-134. DOI: 10.1192/Apt.5.2.126 |
0.354 |
|
| 1998 |
McAllister-Williams RH, Ferrier IN, Young AH. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychological Medicine. 28: 573-84. PMID 9626714 DOI: 10.1017/S0033291798006680 |
0.398 |
|
| 1998 |
Haddad P, Lejoyeux M, Young A. Antidepressant discontinuation reactions. Bmj. 316: 1105-1106. PMID 9552943 DOI: 10.1136/Bmj.316.7138.1105 |
0.327 |
|
| 1997 |
Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. Journal of Psychopharmacology (Oxford, England). 11: 381-92. PMID 9443529 DOI: 10.1177/026988119701100416 |
0.34 |
|
| 1995 |
Young A. Reading About Post-Traumatic Stress Disorder Transcultural Psychiatry. 32: 339-341. DOI: 10.1177/136346159503200306 |
0.326 |
|
| 1995 |
Kirmayer LJ, Young A, Hayton BC. The cultural context of anxiety disorders. Psychiatric Clinics of North America. 18: 503-521. DOI: 10.1016/S0193-953X(18)30037-6 |
0.341 |
|
| 1995 |
Young AH. Biology of depressive disorders parts A & B Journal of Psychosomatic Research. 39: 238. DOI: 10.1016/0022-3999(95)90018-7 |
0.427 |
|
| 1994 |
Kirmayer LJ, Young A, Robbins JM. Symptom attribution in cultural perspective Canadian Journal of Psychiatry. 39: 584-595. PMID 7828110 DOI: 10.1177/070674379403901002 |
0.32 |
|
| Show low-probability matches. |